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Abstract
Tissue damage releases many endogenous mediators including ATP, 
serotonin (5-HT), histamine and prostaglandins such as PGE2 . Many of these 
substances directly excite primary nerve endings to elicit either pain (ATP) or 
both pain and itch (histamine and 5-HT). Prostaglandins do not directly 
activate the nerve endings but are known to sensitise them to histamine and 
5-HT. Although histamine is known to act on sensory neurones via the Hi 
histamine receptor, the receptor subtypes activated by ATP and 5-HT remain 
unclear. In addition, the mechanism by which prostaglandins sensitise the 
nerve endings is unknown. These issues have been investigated in cultured 
rat dorsal root ganglion neurones by using the ratiometric indicator Fura-2 to 
monitor changes in intracellular calcium.
5-HT evoked a rise in [Ca2+]j in approximately a fifth of neurones. This 
proportion remained unchanged when cells were stimulated in a nominally 
calcium free solution or with the 5-HT2 receptor agonist, a-methyl 5-HT. 
Thus, sensory neurones responded to 5-HT via 5-HT2 receptors. PGE2 
sensitised neurones to 5-HT as shown by a leftward shift in the dose 
response curves. A similar leftward shift was seen for the effect of PGE2 on 
the response to histamine. The effects of PGE2 could be mimicked by 
application of forskolin and were blocked by the protein kinase A (PKA) 
inhibitor, H89. This suggests that the sensitisation results from a 
phosphorylation reaction mediated by PKA.
Three quarters of DRG neurones responded to ATP and a similar proportion 
responded to the P2Y agonist, 2-methyl thio ATP. However, although the 
response to the P2Y agonist was reduced by pretreatment with the PLC 
inhibitor U73122 it was not totally abolished, supporting the notion that P2X 
receptors were also involved.
In conclusion, it appears that the calcium responses elicited by histamine and 
5-HT in rat sensory neurons are primarily due to activation of G protein 
coupled receptors and that the sensitivity of these receptors was enhanced 
by PKA mediated phosphorylation.
1
ABSTRACT 1
ABBREVIATIONS 4
LIST OF FIGURES 5
LIST OF TABLES 7
1.0 INTRODUCTION 8
1.1.0 Early studies of itch, pain and inflammation. 10
1.1.1 The triple response. 10
1.1.2 Identification and study of itch and pain spots 11
1.1.3 Is itch a separate sensation? 14
1.1.4 Characterisation of primary afferents mediating 17
itch and pain.
1.1.5 Neurogenic inflammation 21
1.1.6 Sensitisation induced by inflammatory mediators 22
1.2.0 The role of histamine, 5-HT and ATP in the 25
sensations of itch and pain
1.2.1 Histamine 25
1.2.2 Serotonin (5-HT) 27
1.2.3 Adenosine triphosphate (ATP) 31
1.2.4 Prostanoids 33
1.2.5 Activation of G protein linked receptors by 35 
inflammatory mediators
1.3.0 Cultured sensory neurones as a model for the study 39
of peripheral aspects of nociception
1.4.0 Aims of the study 42
2 MATERIALS AND METHODS 44
2.1.0 Primary culture of adult Wistar rat DRG neurones 44
2.2.0 Intracellular calcium imaging 47
2.3.0 Immunohistochemistry 60
2.4.0 Western blotting 64
3 RESULTS 68
3.1 Dorsal Root Ganglion morphology 68
3.2 Sensitivity of sensory neurones to histamine 71
Variation in individual sensory neurones responses 72
to histamine
Effect of concentration on the time course of the 78
[Ca2+], response to histamine
3.3 PGE2 induced sensitisation of sensory neurones to histamine 81
3.4 Chemical and immunological characterisation of the 87 
histamine sensitive neurones
The expression of the Hi receptor in DRG neurones 87
The sensitivity of histamine responsive neurones to 93
other inflammatory mediators 
Summary of findings 96
2
3.5 Characterisation of the calcium response evoked by 97 
sensory neurones upon stimulation by 5-HT
The time course of the calcium responses to 5-HT 99
The calcium entry mechanism/s mediating the 103
response to 5-HT
3.6 The 5-HT receptor subtypes mediating the response 107 
to 5-HT in sensory neurones
Comparison of the calcium response to 5-HT and 110
the selective 5-HT receptor agonists
3.7 Prostanoid-induced sensitisation of the response to 5-HT 114
Summary of findings 119
3.8 The sensitivity of sensory neurones to ATP 120
Variation of individual sensory neurones responses to ATP 120 
Characterisation of the mean [Ca2+]j responses to 122
increasing concentrations of ATP
The source of calcium giving rise to the response 130
of sensory neurones to ATP
3.9 The receptors mediating the ATP response in sensory 134 
neurones
The time courses of the [Ca2+]j responses to ATP 138
and the selective P2Y agonists 
Summary of findings 143
4.0 DISCUSSION 144
4.1 Measurement of intracellular calcium 145
4.2 Chemosensitivity of the DRG neurones 147
The origin of the rise in calcium 150
4.3 The receptors mediating the responses to histamine, 5-HT 153 
and ATP
The calcium response to 5-HT is mediated by 154
5-HT2 rceptors
Receptors mediating the response to ATP 159
4.4 Mechanisms of PGE2 induced sensitisation 166 
of sensory neurones by inflammatory mediators
The sensitised response 168
Mechanism mediating the sensitisation of the 169
response to 5-HT
How does PKA induce sensitisation? 171
How could PKA induced sensitisation 173
enhance cell excitability
4.5 Summary 178
4.6 Future research 180
5.0 REFERENCES 182
6.0 APPENDIX 201
6.1 Drugs and Solutions 201
6.2 Western Blot Protocol 205
3
ABBREVIATIONS
5-HT 5-hyd roxytryptamine
AC adenylyl cyclase
AM acetoxymethyl
AMCA 7-amino-4-methyl-coumarin-3-acetic acid
ATP adenosine triphosphate
ADP adenosine diphosphate
AMP adenosine monophosphate
Ca2+ calcium ions
[Ca2+]j intracellular calcium ions
cAMP cyclic 3\5'-adenosine monophosphate
[cAMP]j intracellular cAMP
CCD charge-coupled device
CGRP calcitonin gene-related peptide
CNS central nervous system
DP PGD2 receptor
DRG dorsal root ganglion
EGTA ethylene glycol-bis(b-aminoethyl ether) N,N,N',N'- 
tetraacetic acid
EP PGE2 receptor
ER endoplasmic reticulum
FP PGF2a receptor
FITC fluorescein isothiocyanate
GDNF glial cell line derived neurotrophic factor
HEPES N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulfonic
acid]
IB4 isolectin B4
IP PGI2 receptor
IPs inositol-1,4,5-trisphosphate
IP3R inositol-1,4,5-trisphosphate receptor
K+ potassium ions
MCPB 1 -(3-chlorophenyl)biguanide
NGF nerve growth factor
PCR polymerase chain reaction
PG prostaglandin
PIP2 phosphatidylinositol-4,5-bisphosphate
PKA protein kinase A
PKC protein kinase C
PLC phospholipase C
TP TXA2 receptor
TRPV1 vanilloid receptor subtype 1
TRITC tetramethyl rhodamine isothiocyanate
TTX tetrodotoxin
t x a 2 thromboxane A2
UTP Uridine 5-triphosphate
4
LIST OF FIGURES
1.0 INTRODUCTION
1.1 -  Three of the proposed neural pathways for itch. 16 
METHODS
2.1 - Schematic representation of the DRG dissection procedure. 45
2.2 - Schematic representation of the experiment apparatus for 51
fluorescence measurement
2.3 - Experiment protocols for the addition of agonists to 54
sensory neurones
2.4 - Typical range of calcium responses evoked by neurones, which 56
have been pre-treated with PGE2 then stimulated with 5-HT 
and high potassium
2.5 - A typical pattern for the ratio changes seen when a cell 59
permeabilised with ionomycin and subsequently challenged 
with solutions containing a high calcium concentration followed 
by a solution nominally calcium free
2.6 - Western Blot identifying a band that corresponds to the apparent 67
molecular mass of the Hi receptor
RESULTS
3.1 - A typical field of cultured DRG neurones at day 1 in culture 69
3.2 - The distribution of neuronal diameters in the sample. 70
3.3 - Histamine sensitivity of sensory neurones varies 73
marginally between strains of rat.
3.4 - Variation in [Ca2+]j signal from individual sensory 75
neurones upon stimulation with 10 mM histamine.
3.5 - The variation in individual neurones responses to 10 mM histamine 77
3.6 - The [Ca2+]j responses to histamine in sensory neurones 79
3.7 - Effect of PGE2 and forskolin on [cAMP]j levels in sensory neurone 82
3.8 - PKA inhibitor, H89, blocks the forskolin-induced sensitisation 85
of the histamine response.
3.9 - The effect of forskolin on the mean calcium response evoked by 86
neurones upon stimulation with 300 pM histamine.
3.10 - The expression of Hi receptor in rat DRG neurones. 89
3.11 - Some histamine-sensitive neurones are sensitive to 95
other inflammatory mediators
3 .1 2 - The concentration response curve for the activation of DRG 98 
neurones by 5-HT
3.13- The time course of the [Ca2+]j responses to 5-HT 100
3.14 - Typical calcium responses evoked by neurones upon 102
stimulation by 100 nM 5-HT 
3.15- The effect of the removal of calcium on the sensory neurones 105
response to 5-HT.
5
3.16 - The response to 5-HT is primarily due to the activation
of the 5 -HT2 receptors.
3.17  - The effect of blocking 5-H T 2 receptors on the [Ca2+]j response
evoked to 5-HT
3.18  - The difference in time courses of the [Ca2+]j responses
evoked by 5-HT and the 5-HT receptor selective agonists.
3.19 - PGE2 pre-treatment enhanced the sensitivity of cells to 5-HT
3.20 - The prostanoid-induced sensitisation of the 5-HT response
can be inhibited by the protein kinase A inhibitor, H89
3.21 - ATP evoked a rise in [Ca2+]j in a large proportion
of sensory neurones
3.22 - The variation in [Ca2+]j responses to ATP
between sensory neurones
3.23 - The time courses of the [Ca2+]j responses to ATP
in cultured sensory neurones
3.24 - Typical examples of calcium responses evoked in DRG
neurones by 3 pM ATP
3.25 - The extended time course of the response to ATP
3.26 - Removal of calcium does not significantly affect the
percentage of cells responding to ATP
3.27 -  The effect of calcium removal on the [Ca2+]j response
evoked by ATP
3.28 - The majority of the cells responding to ATP
possess P2Y receptors
3.29 - The log dose response curves for 2 MeS-ADP and ATP
3.30 - The time course of the [Ca2+]j responses to ATP
and the P2Y agonists 2 MeS-ATP and 2 MeS-ADP
3.31 - The effect of the PLC inhibitor, U73122,on the [Ca2+]j response
to 30 pM ATP
Discussion
4.1 -  The classes of 5-HT receptor and their coupling
4.2 -  The classes of purinergic receptors and their coupling
4.3 -  The possible mechanisms employed by PKA to induce
sensitisation and how PKA could enhance cell excitability
108
109
111
116
118
121
123
126
128
129
131
132
136
137 
139
141
157
161
174
6
LIST OF TABLES
INTRODUCTION
1.1- Stimuli that elicit or augment itch 14
1.2 - Classification of the primary afferent neurones. 18
1.3 - Classification of the histamine receptor subtypes 27
1.4 - Classification of the prostaglandin receptor subtypes. 34
1.5 - Classes of G protein a subunits 36
METHODS
2.1 - The variation in 340/380 ratio correlates to the concentration of 59
free intracellular calcium.
2.2 - The properties of the fluorescent markers used. 60
2.3 - The concentrations of the primary and secondary antibodies. 62
RESULTS
3.1 - Time to peak and amplitude of the [Ca2+]i response to histamine 78
3.2 - Time to peak and amplitude of the [Ca2+]j responses to 5-HT 103
3.3 - The variation in the characteristics of the calcium responses to 113
5-HT in different conditions and to the 5-HT receptor 
selective agonists
3.4 - PGE2 pre-treatment enhanced the percentage of cells 114
responding to 5-HT
3.5- Time to peak and amplitude of the [Ca2+]j responses to ATP 125
3.6 - The effect of the removal of external calcium on the 130
characteristics of the response to ATP
3.7 - The time to peak and amplitude of the calcium responses to ATP 142
and the selective agonists
7
1.0- Introduction
Nociception refers to the detection of noxious stimuli by the nervous system. 
Specialised sensory receptors termed nociceptors are activated in the periphery 
by noxious stimuli. Nociceptors transmit impulses to the central nervous system 
(CNS), where motor responses are initiated and the sensations of itch or pain 
are perceived. Itch (Pruritus) is an unpleasant sensation associated with the 
desire to scratch. Although itch has been written about for centuries it remains 
poorly understood. Its physiological role, like pain, is to act as a self-protective 
mechanism to help defend the skin against harmful external agents including 
parasites and plants.
While most people’s experience of the sensation is limited to the occasional 
insect bite there is a wide diversity of diseases associated with itch. It is a 
dominant symptom of skin diseases while many systemic diseases, such as 
chronic renal failure, liver diseases and HIV are also accompanied by persistent 
or recurring itch attacks (Twycross et al., 2003). Initially the associated 
scratching and pinching has an antipruritic effect (Greaves and Wall, 1998). 
However, these actions can cause tissue damage, which in turn can lead to 
infection and further medical problems. The scratching can also evoke the 
release of inflammatory mediators that potentially induce or aggravate itch 
resulting in an itch-scratch cycle.
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The development of effective treatments for itch have been hampered by the 
lack of reliable models resulting in the lack of detailed knowledge about target 
cells and the neural pathways involved. Due to the highly subjective nature of 
itch, the sensation is difficult to study objectively in man and there are currently 
few reliable animal models. Humans can distinguish the distinct features of the 
itch and pain sensations, thus are able to quantify the intensity of itch itself 
(Magerl et a/., 1990). Two broad approaches are used to directly measure itch: 
subjective recording using a visual scale or experimental psychophysical 
technique. In the first technique pruritic stimuli are applied and subjects rate the 
level of perceived itch using a visual scale. However, this technique has fixed 
end points, a limited range of measurements and does not give any information 
on neural pathways or signalling molecules. Perceptual matching techniques 
are used for psychophysical assessment of itch in subjects. An electrical 
stimulus is applied to the skin of the finger and the subject halts the stimulus 
when the amplitude of the sensation matches the intensity of the itch 
experienced during histamine iontophoresis in the inside of the forearm. This 
approach is not limited by visualised predetermined limits and gives a 
continuous indication of intensity. Much of the early work on itch was thus 
collected from human subjects using psychophysical studies.
In animal models, itch has to be measured by a behaviour that is only elicited by 
pruritic stimuli and not by other sensory stimuli. Scratching in animals is a 
regular occurrence (e.g. grooming) and thus may not be a true indicator of itch. 
However, a recent behavioural study showed that intradermal injections into the
rostral part of the back of the mouse showed that pruritic but not algogenic 
stimuli elicited scratching at the injected site by the hind paw (Kuraishi et al.,
1995). This approach maybe of value in examining different treatments for itch.
1.1.0- Early studies of itch, pain and inflammation
1.1.1- The triple response
When tissue is damaged a vascular response occurs which consists of three 
independent parts (Lewis, 1927). This response was termed the triple response, 
which consists of:
1. A local area of redness appears immediately at the site of injury due to 
local dilatation of the arterioles.
2. A red flare spreading over several centimetres rapidly develops around 
the injury.
3. As the flare subsides, an area of oedema develops at the site of the injury 
due to the leakage of fluid from the post capillary venules.
The area of inflammation becomes sensitive to innocuous stimuli such as 
clothing rubbing which is termed hyperalgesia. Lewis et al (1927b) first 
observed that this hyperalgesia not only occurred within the injured tissue 
(primary hyperalgesia) but extended into the region of the flare and beyond into 
the normal tissue outside the injured area (secondary hyperalgesia). Primary 
hyperalgesia is thought to result from a decrease in the firing threshold of 
peripheral terminals of primary afferent neurones and thus mediated peripherally 
(LaMotte et al., 1982, LaMotte et al., 1983,). Within this area of secondary
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hyperalgesia innocuous stimuli such as light stroking produce pain (allodynia) 
while noxious stimuli produce abnormally intense and prolonged pain. Pruritic 
stimuli can also induce a secondary alloknesis where light tactile stimulation 
evokes itch (Graham et al., 1951). LaMotte et al (1991) showed that secondary 
hyperalgesia could be prevented by anaesthetic blockade of peripheral nerves 
innervating the site of capsaicin application. This evidence suggests that 
secondary hyperalgesia is mediated by central sensitisation. A more detailed 
overview of the mechanisms involved in the induction of neurogenic 
inflammation and the accompanying hyperalgesia is given below (p.21).
1.1.2- Identification and study of itch and pain spots
In 1922, Von Frey demonstrated that the sensory modalities including itch and 
pain had a punctate distribution in the skin. Using a hair-like plant bristle 
mounted on a handle he was able to map out the skin for sensory spots uniquely 
sensitive to itch. Using electrical stimulation the pruritic nature of the itch spots 
was confirmed (Bishop, 1943). However, both the electrical and mechanical 
experiments demonstrated that weak stimuli at these spots gave rise to itch 
while stronger stimuli at the same spots produced pain. Shelley and Arthur 
(1957) correlated the physiological activation of these spots with the histology of 
the skin. Using a modification of the classical methylene blue nerve stain they 
studied large superficial shavings of skin in which active or inactive cowhage 
(Mucuna pruriens) spicules remained as a marker. Subsequently the skin 
biopsies showed that itch and pain spots possessed a greater number of fine
11
free nerve endings (Von Frey, 1922, Shelley and Arthur, 1957) than the 
neighbouring areas. The early experiments also used various methods of 
chemical stimulation to induce pain and itch (e.g. iontophoretic application of 
irritants to the skin, intradermal injection, pricking the skin through a drop of 
agonist). The conjunctival sac was even used to record the irritant effects of 
histamine and demonstrate the mode of action of capsaicin. Nevertheless, 
many of these early techniques did not produce reliable and reproducible 
results.
In 1964 Keele and Armstrong introduced the cantharidin blister technique. 
Cantharidin, the active component of cantharides, is an anhydride of cantharidic 
acid which occurs in blister beetles. Cantharidin was applied to the skin for four 
to six hours. After removal, a red area was left which over time developed into a 
blister. The fluid and raised epidermis was removed and algogenic or pruritic 
agents were applied to the blister base. Acetylcholine, 5-HT and ATP evoked 
pain when applied to an exposed blister base. The latency between application 
and onset of pain varied with mediator. Acetylcholine provoked an immediate 
pain upon application while 5-HT and plasma kinins evoked a sensation of pain 
only after a period of time. Exposure of a blister base to histamine and agents 
that liberate histamine (e.g. compound 48/80) evoked itch with a delayed onset. 
Thus, the blister base experiments demonstrated that a number of chemicals 
could be applied to the exposed base to evoke reproducible sensations of itch or 
pain. However, this technique raised the issue of sensitisation, a key feature of 
itch and pain. Shelley and Arthur (1957) believed that the cantharidin blister
technique was unsuitable for the study of pruritic agents because the nerve 
endings were already sensitised prior to any agonist application. The sensitised 
nerve endings in an exposed blister base would in fact resemble those at the 
site of tissue damage or inflammation.
To overcome this limitation, Shelley and Arthur (1957,1955, Arthur and Shelley, 
1955) used the spicules of cowhage to study the itch spots. Their technique 
allowed minute quantities of fluid to be injected at different depths into the 
epidermis. They demonstrated that the spicules of cowhage themselves 
contained a pruritic which proved to be a proteolytic enzyme termed mucunain. 
The insertion of boiled spicules into the skin did not elicit itch, so they could be 
impregnated with different test solutions and used to investigate peripheral 
aspects of itch. A range of compounds including histamine, trypsin and papain 
were shown to activate itch spots, clearly establishing the importance of 
chemical mediators in the process of itch (Arthur and Shelley, 1955, Shelley and 
Arthur, 1957). Subsequently, it has been found that pruritus can be evoked in 
the skin directly by mechanical and thermal stimuli or indirectly through chemical 
mediators (see Table 1.1, p.14). These mediators can elicit itch by stimulating 
the nerve endings directly e.g. histamine and papain (protease) or by causing 
mast cell degranulation thus releasing histamine e.g. compound 48/80.
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Table 1.1 -  Stimuli that elicit or augment itch
Physical Mechanical Touch, PressureThermal Warming
Chemical
Non Specific Irritants Acids, Alkalis
Inflammatory Mediators Histamine, 5-HT, Prostaglandins
Histamine Releasing Substances Compound 48/80
Peptidases Trypsin
Neuropeptides Substance P
Opioids Morphine
(adapted from McMahon and Koltzenburg, 1992).
1.1.3- Is itch a separate sensation?
The close relationship between itch and pain has led many to contend that itch 
is a subliminal form of pain (e.g. Von Frey, 1922, Lewis etal., 1927a). While itch 
and pain share some features they are distinct sensory modalities and can be 
distinguished in the following ways. While pain can be elicited in most tissues, 
itch sensations can only be elicited in the mucous membranes, the superficial 
layers of the skin and the conjunctiva. Arthur and Shelley (1959) showed that 
the removal or destruction of the epidermis abolished itch but not cutaneous 
pain. Moreover, behavioural studies have shown differences in the protective 
reflexes elicited by itch and pain: itch evokes the scratch reflex, while cutaneous 
pain leads to the withdrawal reflex. Differences also occur in their treatment as 
the pain relieving non-steroidal anti inflammatory drugs (e.g. indomethacin and 
aspirin) cannot alleviate itch and systemic administration of opioids actually 
potentiates itch (Ballantyne et al., 1988). Nevertheless, itch induced by the 
injection of a cowhage spicule on the forearm can be abolished by a pinprick 
applied locally. Therefore, painful stimuli can mask itch and the two sensations
rarely coexist in the same skin region (Bickford, 1938, Graham et al., 1951, 
McMahon and Koltzenburg, 1992, Greaves and Wall, 1996, Ward et al., 1996). 
To conclude, the evidence supports the notion that itch is a unique sensory 
experience that is qualitatively distinct from pain.
Early work failed to identify a subset of primary afferent fibres or specific 
mechanisms that could explain all the features of itch and pain. In 
consequence, four rather different theories of itch have been proposed (see 
Figure 1.1):
1. The specificity theory proposes that there are itch specific neurones i.e. a 
group of afferent fibres and central neurones exists that only respond to 
pruritic stimuli.
2. The intensity theory hypothesizes that both itch and pain are mediated by 
the same set of neurones and the sensation perceived is due to the 
intensity of the stimuli. Low activity in the nociceptive fibres signals itch 
while higher activity signals pain.
3. The selectivity theory suggests that pain and itch sensations are 
mediated by specific subsets of fibres. Thus itch sensations are encoded 
by a specific set of afferents having different central connectivities to 
those signalling pain.
4. The pattern theory suggests primary afferents are not specific for either 
sensation but instead itch is encoded by the temporal or spatial firing of 
the afferents.
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Figure 1.1 -  Three of the proposed neural pathways for itch.
The afferent neurones responsive to histamine are labelled H, while M indicates 
the afferent neurones sensitive to noxious agents such as mustard oil (adapted 
from McMahon and Koltzenburg 1992).
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However, investigations using transcutaneous (Tuckett, 1982) and intraneural 
electrical stimuli (Torebjork and Ochoa, 1981) in humans showed that itch 
sensations could not be changed into pain by the frequency or pattern of 
stimulation of the nociceptive fibres. This evidence is inconsistent with the 
intensity and pattern theories. The remaining two theories will be discussed 
further in the section discussing which fibres mediate the itch and pain 
sensations (p.21).
1.1.4- Characterisation of primary afferents mediating itch and pain.
Primary afferent nerve fibres connect sensory receptors to the CNS. Their cell 
bodies are located in the dorsal root and trigeminal ganglia. Upon stimulation of 
the sensory receptors, information is transmitted to the CNS by trains of nerve 
impulses in primary afferent nerves. The properties of these fibres differ 
markedly depending on the sensory modality. The primary afferent fibres can 
be classified into three main types on the basis of their diameter, structure and 
conduction velocity (see Table 1.2). Nociceptors are a subpopulation of 
peripheral afferent fibres that are activated by noxious stimuli. Nociceptors are 
unusual sensory cells in that they respond to a wide spectrum of physical (heat, 
and cold), chemical (acid, irritants and inflammatory mediators) and mechanical 
(stretch and pressure) stimuli. The heterogeneous nature of nociceptors is 
reflected in the neurotransmitters they utilise, the receptors and ion channels 
they express, their conduction velocities and their ability to be sensitised during 
inflammation, injury and disease. However, nociceptors are only activated at 
stimulus intensities that are capable of causing tissue damage.
Table -1.2 -  Classification of the primary afferent neurones.
Fibres Diameter
Conduction
Velocities
(ms’1)
DRG
neurones
DH laminae 
innervated
Sensory
function
Aa+p
Large 
(>10 nM) 
Myelinated
Fast
30-100
Large 
Type A lll-VI
Proprioception 
vibration and 
touch
A8
Medium 
(2-6 nM) 
myelinated
Intermediate
12-30 Medium
l / l lo
lll-V
Thermoreception 
(cold), touch and 
pain
C
Small 
(0.4-1.2 nM) 
Unmyelinated
Slow 
0.5-2.0
Small 
Type B
l / l lo
IV/V, X
Thermoreception 
(warm), touch, 
pain and itch
Capsaicin is an irritant compound in the capsicum plant that is capable of 
producing an intense burning pain when intradermally injected into humans 
(LaMotte et a/,. 1992). Electrophysiological studies showed that low 
concentrations of capsaicin excited specific subsets of sensory neurones 
including almost all C fibre polymodal and thermo nociceptors and some A5 fibre 
polymodal nociceptors (Heyman and Rang, 1985). These fibres are also excited 
by bradykinin and low pH. Thus capsaicin sensitivity has proven to be an 
extremely useful functional marker for nociceptive fibres (Fitzgerald, 1983, 
Holzer, 1991).
The thinly myelinated A8 fibres elicit a rapid first phase of pain, sharp in nature 
while unmyelinated C fibres evoke a second wave of dull pain. The following 
evidence suggests that itch, like pain, is primarily mediated by unmyelinated C 
fibres. The differential blocking of the myelinated fibres in the skin does not 
abolish histamine-induced itch (Handwerker et al., 1987). The induction of itch 
after iontophoretic application of histamine to the skin is characteristically slow
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(30-60 seconds after the stimulus) (Schmelz, 2001). The destruction of the 
unmyelinated nerve endings by pre-treatment with capsaicin (Simone et al.,
1996) abolished the histamine-induced itch (Handwerker et al., 1987). When C 
fibre conduction was blocked by peripheral nerve compression, itch was 
abolished (Handwerker et al., 1987). This evidence clearly suggests itch is 
mediated by unmyelinated C fibres.
Microneurography is used extensively to study discharge patterns of human 
cutaneous C fibres. This technique showed that nociceptive C fibres are 
heterogeneous. They can be classified by their responsiveness to chemical, 
mechanical and thermal stimuli (Bessou and Perl, 1969, Torebjork and Hallin, 
1974). C fibres that are excited by Von Frey hair stimulation are termed 
mechano-responsive (CM). Thermo-responsive C fibres (CH) are excited by 
noxious radiant heat stimuli. However, some C fibres are responsive to more 
than one stimulus. The most common type of C fibres are excited by noxious 
chemical, mechanical and thermal stimuli and thus are referred to as polymodal 
fibres (Bessou and Perl, 1969, Beck et al., 1974, Lynn and Carpenter, 1982, 
Torebjork, 1974). They are strongly activated by mustard oil (Tuckett and Wei, 
1987, Handwerker et al., 1991) but are either insensitive to or very weakly 
activated by, histamine (Handwerker et al., 1991). The response pattern of 
polymodal C nociceptors does not match the prolonged itch sensations induced 
by intradermal injection of histamine (Simone et al., 1987) or by iontophoretic 
application of histamine (Handwerker et at., 1987, Magerl et al., 1990). This
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evidence suggests that polymodal C fibres mediate pain yet itch is unlikely to be 
mediated by this same subset of C fibres.
Using a refined marking microneurography technique a new subset of mechano- 
insensitive C fibres (CMj) has been identified in human skin (Schmidt et al., 
1995). A subgroup of these mechanoinsensitive C fibres was found to be 
sensitive to histamine (Schmelz et al., 1997). The responses of these C fibres 
to iontophoretic application of histamine into the skin (Schmelz et al., 1997) 
parallel the itch rating of the subjects (Magerl et al., 1990). It has been 
proposed that these fibres mediate the itch response in humans.
Recently in cat, the iontophoretic application of histamine to the skin was shown 
to selectively excite a class of lamina 1 spinothalamic tract neurones. The 
responses of these neurones parallel the pure itching sensation induced by 
histamine in humans (Magerl et al., 1990) and match the responses of the 
peripheral histamine-sensitive mechano-insensitive nociceptive C fibres 
(Schmelz etal., 1997, Andrew and Craig, 2001).
The evidence reviewed above suggests that different subsets of C fibres 
mediate the two sensations. The discovery of histamine-sensitive mechano­
insensitive C fibres provides evidence for a pathway specific for the processing 
of itch (Schmelz et al., 1997, Andrew and Craig, 2001,). Nevertheless, although 
the peripheral mechano-insensitive nociceptors showed sustained responses to 
a number of pruritic agents, they were additionally excited by some algogenic
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substances e.g. bradykinin, capsaicin (Schmelz et al., 2003). Therefore this 
new subset of C fibres suggests that some afferents are excited by both pruritic 
and algogenic stimuli. This evidence argues against the specificity theory which 
states that there are itch specific neurones. However, it supports the selectivity 
theory, which proposes that the histamine sensitive afferents also respond to 
algogenic agents. Differentiation between the sensations reflects the central 
processing.
1.1.5- Neurogenic Inflammation
In 1901, Bayliss first reported that the electrical stimulation of the dorsal roots 
evoked vasodilatation which was unaffected by sympathectomy or division of the 
dorsal root between the ganglia and spinal cord. He postulated that these 
neurones not only conduct afferent information to spinal cord but also served an 
efferent function (Bayliss, 1901). As mentioned earlier, injury to the skin results 
in the triple response characterised by redness at the site of injury followed by a 
flare spreading over several square centimetres. This is followed by the 
development of local oedema at the site of injury.
Lewis (1927) believed that the spread of the flare was due to a local axon reflex, 
which involves the antidromic activation of connecting nerve fibres that innervate 
the adjacent skin. This notion is supported by the following evidence: activation 
of the axon collaterals release neuropeptides from their terminals. These act on 
target cells (e.g. mast cells, arteriolar smooth muscle) to produce a range of 
effects including mast cell degranulation, vasodilatation, (visible as flare
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surrounding the site of injury) and plasma protein extravasation (which gives rise 
to a wheal). These are collectively termed neurogenic inflammation 
(Jancso et a/., 1967, Holzer, 1988, Geppetti and Holzer, 1996). Although 
nociceptive fibres contain a variety of neuropeptides, most of the evidence 
suggests that calcitonin gene-related peptide (CGRP) and substance P appear 
to be the main initiators of neurogenic inflammation (Holzer, 1988). Direct 
application of substance P to peripheral tissue produces vasodilatation, 
increased vascular permeability (Lembeck and Holzer, 1979) and degranulation 
of mast cells. The degranulation of the mast cells results in the local release of 
histamine (Ebertz et a/., 1987). This is consistent with the observation that the 
injection of histamine into the skin mimics almost exactly the triple response 
(Lewis, 1927). CGRP also evokes vasodilatation and potentiates the plasma 
extravasation induced by other inflammatory mediators e.g. substance P and 
histamine (Brain et al., 1985, Gamse and Saria, 1985). The administration of 
substance P or CGRP agonists mimics the symptoms of neurogenic 
inflammation while the receptor antagonists and antibodies attenuated them 
(Lembeck et al., 1982, Couture and Cuello, 1984). Recent studies have 
suggested that other mediators released during tissue damage (e.g. nerve 
growth factor) may also play a role in the development of inflammation (Lewin et 
al., 1994; Koltzenburg etal., 1999).
1.1.6- Sensitisation induced by inflammatory mediators
Hyperalgesia occurs when non-noxious stimuli are perceived as painful or when 
the intensity of pain perceived from noxious stimuli increases. Nociceptor
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sensitisation is thought to underlie the phenomenon of peripheral hyperalgesia. 
It is characterised by lower firing thresholds for nociceptive activity, increased 
spontaneous activity and increased frequency of firing to suprathreshold stimuli 
(Meyer et al., 1994). Sensitisation is triggered by a number of extracellular 
mediators released from damaged or inflamed tissue.
During neurogenic inflammation a large number of biologically active substances 
are released. A number of these substances are known to sensitise the 
peripheral nerve endings to stimulation by other mediators. To induce
peripheral sensitisation these mediators can either act directly on primary
afferent nerves or indirectly by stimulating other non-neuronal or neuronal cells. 
These cells then release hyperalgesic agents that can then act on primary 
afferent nerves. These mediators include bradykinin, ATP, 5-HT and many 
products of the arachidonic acid pathway (e.g. prostaglandin E2 (PGE2)). 
Although bradykinin, ATP and 5-HT are primarily known for their potent
algogenic properties they also have a secondary action that can induce
peripheral sensitisation.
Inflamed tissue often contains high concentrations of prostaglandins. The 
activation of phospholipase A2 generates arachidonic acid, which in turn is 
metabolised by cyclo-oxygenases to produce various prostaglandins. The 
application of PGE2 to an exposed blister base failed to evoke pain and 
intradermal injections of prostaglandins alone do not normally elicit pain 
(Ferreira, 1972). However, early animal studies showed that prostaglandins
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reduced the intensity of noxious stimuli needed to elicit various escape 
behaviour (Ferreira et al 1978). In agreement, Hamilton et al (1999) showed 
that animals pre-treated with prostaglandins required lower concentrations of 
ATP for nocifensive responses. In man, peripheral sensitisation is observed as a 
heightened perception of pain (Handwerker and Reeh, 1991, Handwerker and 
Kobal, 1993).
These behavioural observations are supported by both in vivo and in vitro 
experiments, which show that the co-administration of a nociceptive agent with 
prostacyclin (PGb) or PGE2 causes a dramatic increase in the responsiveness 
of the neurones (Ferreira et a/., 1978, Baccaglini and Hogan, 1983). 
Prostaglandins are known to act directly on peripheral terminals of nociceptive 
afferents to produce hyperalgesia (Taiwo and Levine, 1989). The elimination of 
all known indirect pathways such as inhibition of cyclo-oxygenase pathways of 
arachidonic acid metabolism, depletion of sympathetic postganglionic neurones 
and depletion of polymorphonuclear leukocytes did not affect the hyperalgesia to 
mechanical stimuli induced by PGE2. The prostaglandins are thought to produce 
their effects by binding to specific receptors on the sensory neurones enabling 
them to lower the firing threshold of these neurones (Schaible and Schmidt 
1988). The mechanisms involved in the prostaglandin-induced sensitisation will 
be explored in the discussion.
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1.2.0 - The role of histamine, 5-HT and ATP in the sensations of itch and 
pain.
After tissue damage or inflammation a large number of mediators are released 
into the extracellular milieu. The early work of Shelley and Arthur (1957, 1959) 
and Keele and Armstrong (1964) demonstrated that histamine, 5-HT and ATP 
could evoke the sensations of itch and pain. This study is primarily concerned 
with the actions of these mediators on the intracellular concentration of calcium 
in primary sensory neurones. Below is a description of the tissue sources, the 
actions in the periphery and the receptors for each of these important 
inflammatory mediators.
1.2.1- Histamine
Histamine is found in nearly every mammalian tissue with particular abundance 
in the skin, lungs, gut and gastric mucosa. Histamine is formed by 
decarboxylation of the amino acid histidine by the enzyme L-histidine 
decarboxylase (Tanaka and Ichikawa, 2001). In the peripheral tissues, histamine 
is stored in mast cells, basophils, enterochromaffin cells and some neurones. In 
mast cells and basophils it is stored in intracellular secretory granules loosely 
bound to heparin and chondroitin-4-sulphate (Soil et al., 1981, Beaven et al., 
1983). The concentration of histamine in these secretory granules is in the 
molar range (Beaven et al., 1983). Inflammatory and chemical stimuli can 
trigger the release of histamine from mast cells by producing a rise in 
intracellular calcium, which in turn activates a calcium dependent exocytosis 
(Lagunoff et al., 1983) resulting in the degranulation of the mast cell. Following
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degranulation, the histamine concentration in the extracellular space adjacent to 
the mast cell is in the region of 15-30 mM although it falls progressively with time 
(Nicolson et al., 2002). However, those nerve endings in close proximity (<100 
nm) to degranulating mast cells (Dimitriadou et al., 1997) will experience 
millimolar concentrations of histamine.
The injection of histamine into the skin almost exactly mimics the triple response 
(Lewis, 1927). Lewis (1927) also noted that the triple response induced by 
histamine was frequently accompanied by itch. Many other investigators have 
since confirmed the pruritogenic action of histamine by a number of different 
methods. The application of histamine to an exposed blister base (Keele and 
Armstrong, 1964) and the intraepidermal injection of an inactivated cowhage 
spicule coated with histamine (Shelley and Arthur, 1957) both induced itch. 
Nowadays, histamine is frequently used in experimental models of itch as 
iontophoretic application onto the skin elicits a pure and almost graded 
sensation of itch (Magerl et al., 1990). Histamine is firmly established as a 
potent pruritic as well as a major mediator of inflammation.
Histamine Receptors
The membrane histamine receptors have been classified into four distinct 
subtypes (Hi, H2i H3 and H4) all of which are G protein coupled (see Table 1.3). 
All the receptors have been cloned: Hi and H2 in 1991 (Gantz et al., 1991, 
Yamashita et al., 1991), H3 in 1999 (Lovenberg et al., 1999) and H4 in 2001 
(Nguyen et al., 2001, Zhu et al., 2001). The histamine receptor subtype
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mediating the calcium response in DRG neurones has previously been 
characterised (Nicolson et al., 2002). Here, a brief summary of the histamine 
receptor subtypes is given (see Table 1.3).
Table 1.3 -  Classification of the histamine receptor subtypes.
Receptor
Subtype G protein
Transduction
Mechanism Location
HiR Gq Ca mobilisation
Widely distributed 
PNS+CNS
H2R G s
Activates
adenylyl
cyclase
Stomach .Heart .cells of 
immune system
h3r Gi/o
Inhibits adenylyl 
cyclase Limited to brain
h4r Gj/o Inhibits adenylyl cyclase
Bone marrow, 
leukocytes, small 
intestine
Application of histamine to rat DRG neurones elicits a rise in calcium in a small 
sub-population of sensory neurones. This calcium response is blocked by the 
application of Hi receptor antagonist, meypyramine, but not by the application of 
antagonists of H2 receptor (cimetidine) or H3 receptor (thioperamide) (Nicolson 
et al., 2002). Thus, the Hi receptor elicits a rise in intracellular calcium in 
cultured sensory neurones.
1.2.2-Serotonin (5-HT)
The monoamine 5-HT, like histamine, is widely distributed throughout the body. 
It is synthesised from tryptophan, which is derived from dietary sources. The 
prominent sources of 5-HT in the periphery are platelets and mast cells in rats
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and platelets in humans (Graziano, 1988). Circulating levels of free 5-HT in 
plasma are low since platelets accumulate 5-HT by active transport and store it 
in high concentration. 5-HT is one of the mediators in the inflammatory soup 
released from platelets, mast cells, and basophils that infiltrate an area of tissue 
damage. The following evidence supports the role of 5-HT in inflammation, 
hyperalgesia, itch and pain.
In the skin, iontophoretic application of 5-HT induces wheal, flare and itch. Itch 
and the vasocutaneous reactions induced by 5-HT were significantly weaker 
than those induced by iontophoretic application of histamine (Weisshaar et al., 
1997). Moreover, intradermal injections of 5-HT provoke a weaker sensation of 
itch than induced by histamine (Fjellner and Hagermark 1979).
Early studies showed that application of 5-HT to an exposed blister base gave 
rise to a sharp but transient pain sensation (Keele and Armstrong, 1964, 
Richardson et al., 1985). Moreover, intradermal injections of 5-HT evoked pain 
(Lindahl, 1961, Keele and Armstrong, 1964). 5-HT has long been recognised as 
a potent excitant of afferent fibres in a wide variety of peripheral nerves (Wallis 
et al., 1982, Christian et al., 1989). Electrophysiological studies show that 5-HT 
induces pain due to the excitation of unmyelinated C fibres (Beck and 
Handwerker, 1974). It has long been believed that the direct activation of 
nociceptive fibres is via the activation of 5-HT3 receptors as pain induced by 
application of 5-HT to an exposed blister base can be abolished by application 
of 5-HT3 antagonists (Richardson et al,. 1985). However, more recent studies
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have suggested that 5-HT2 receptors may also be involved. Discharge of C 
fibres elicited by 5-HT are inhibited by the 5 -HT2 receptor antagonist, ketanserin, 
but not by the 5-HT3 receptor antagonist, MDL72222 (Grubb et al,. 1988). This 
evidence suggests the involvement of multiple receptor types in the mediation of 
pain. Application of 5-HT ligands was shown both to hyperpolarize (Todorovic 
and Anderson, 1992) and to depolarise (Molokanova and Tamarova, 1995) 
sensory neurones. The effects produced were dependent on the population of 
neurones stimulated and on the selectivity of the ligand applied. The variation in 
the responses seen in DRG neurones could also be explained by the interaction 
of 5-HT with multiple receptor subtypes.
5-HT seems to have a number of different roles in peripheral pain transduction. 
Bleehen and Keele (1977) showed that it acts synergistically with adenosine to 
induce pain when applied onto an exposed blister base. Furthermore, when a 
low dose of 5-HT was combined with other inflammatory mediators and injected 
into the hind paw of an animal it induced a synergistic increase in paw lifting and 
licking-features characteristic of a pain response (Hong and Abbott, 1994). This 
effect was observed even when the co-administrated mediator was not able to 
induce a pain response by itself (Hong and Abbott, 1994). This evidence 
strongly supports a role for 5-HT in the potentiation of pain produced by other 
inflammatory mediators.
A further action of 5-HT is the induction of hyperalgesia to thermal and 
mechanical stimuli. Injections of 5-HT into the foot pad of rats reduced the paw
withdrawal latency to radiant heat (Tokunaga et al,. 1998). 5-HT can also 
sensitise the primary afferent terminals to mechanical stimuli. This hyperalgesic 
effect was dose dependent (Taiwo and Levine, 1992). The onset of 
hyperalgesia was rapid, suggesting that 5-HT was acting directly on the primary 
afferent neurones. This was confirmed when the elimination of all known indirect 
pathways such as blockage of cyclo-oxygenase pathways of arachidonic acid 
metabolism, depletion of sympathetic postganglionic neurones and depletion of 
polymorphonuclear leukocytes failed to attenuate the mechanical hyperalgesia 
induced by 5-HT. This is consistent with the notion that hyperalgesia can be 
evoked by a direct action of 5-HT on the peripheral nerve endings.
The evidence reviewed above illustrates the range of different effects produced 
by 5-HT in the periphery. Seven families of 5-HT receptors have been identified 
(Hoyer et al., 1994). All except one (5 -HT3) of the 5-HT receptors couple to G 
protein cascades that modulate the intracellular concentration of second 
messengers. To acquire a better understanding of the range of effects mediated 
by 5-HT, there is a need to investigate the multiple 5-HT receptors expressed on 
primary afferent fibres. It is important to understand how these receptors 
interact with each other and other inflammatory mediators. The characteristics 
of the 5-HT receptor subtypes which appear to be involved in nociception will be 
detailed, in conjunction with my results, in the discussion.
5-HT plays a complex role in many of the features of nociception in the central 
nervous system. In the spinal cord 5-HT is released primarily from the raphe
spinal serogeneric pathway, which contributes to the descending inhibition of 
spinal pain transmission. The released 5-HT inhibits the responses of neurones 
in the dorsal horn to noxious stimuli, producing an analgesic effect. Thus the 
central actions of 5-HT produce analgesia, while it has an excitatory action on 
peripheral nociceptors.
1.2.3- Adenosine triphosphate (ATP)
ATP is an essential metabolite involved in energy transfer in all cells. It is 
present in millimolar concentrations in the cytosol of all cell types. Cytoplasmic 
ATP is utilised for driving many pumps (e.g. Na/K ATPase, Ca-ATPase), for 
GTP synthesis and by many G proteins and various protein kinases. Apart from 
the cytoplasmic and mitochondronial stores, ATP is present in synaptic vesicles 
of some nerve terminals where it is co-localised with acetylcholine and 
noradrenaline. Extracellular levels of ATP are normally maintained in the nM 
range, which are achieved by the expression of ecto-nucleotidase in most cells. 
These enzymes can sequentially degrade ATP to ADP, AMP, adenosine and 
inosine within cells. Nevertheless, upon tissue damage ATP is released from a 
variety of sources including primary nerve afferents, sympathetic nerves, 
endothelial and epithelial cells.
Over thirty years ago, Burnstock first proposed the notion of purinergic 
transmission, which initially met with much resistance. Non adrenergic non 
cholinergic nerves are now known to utilise ATP as a transmitter when supplying 
the smooth muscle of the intestine and bladder (Burnstock et al., 1972, 1978).
Once ATP was established as a neurotransmitter there was considerable 
interest into its possible role in pain. ATP is one of the inflammatory mediators 
released in the milieu during inflammation or tissue damage. Bleehen and 
Keele (1977) showed that exogenously applied ATP to an exposed blister base 
induced pain. The actions of ATP as a potent algogen were confirmed when 
intracutaneous injections (Hilliges et al., 2002), intradermal injections (Burnstock 
and Wood, 1996, Coutts et al., 1981) and iontophoretic application to the skin 
(Hamilton et al., 2000) all evoked an intense pain. In behavioural studies, 
injections of ATP into the hind paw of rats resulted in dose-dependent 
nocifensive behaviour (Bland-Ward and Humphrey, 1997, Hamilton etal., 1999). 
In humans, ATP was found to activate a sub population of C nociceptors and 
some A6 fibres (Hilliges et al., 2002, Schmelz et al., 2003). Moreover, ATP has 
been shown to elicit fast excitatory responses in primary afferent fibres (Krishtal 
et al., 1983, Lewis et al., 1995). This evidence supports the notion that ATP is a 
mediator of pain at primary afferent nerve endings.
Extracellular ATP activates receptors collectively called P2 purinoceptors 
(Burnstock and Kennedy, 1985). They are distinct from the Pi receptors that are 
activated by the ubiquitous endogenous purine adenosine. The P2 
purinoceptors can be subdivided into two major classes: P2X (which are ligand 
gated cation channels) and P2Y (which are G-protein coupled receptors) 
(Abbracchio and Burnstock, 1994). A large number of ATP receptors have been 
identified and there is considerable debate as to the receptors involved in
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mediating pain and hyperalgesia. The P2 receptors will be further reviewed in 
the discussion.
1.2.4- Prostanoids
Arachidonic acid is a ubiquitous component of cells. It is generated from 
membrane phospholipids via activation of phospholipase A2 (Shimizu and Wolfe, 
1990). Arachidonic acid is metabolised by two different enzymes, 
cyclo-oxygenases give rise to various prostanoids and lipooxygenases give rise 
to various leukotrienes (Rang et al., 1995). In response to tissue injury, 
prostaglandins are synthesised de novo from arachidonic acid. The 
prostaglandins produced in the early stage of inflammation play a role in the 
dilatation of blood vessels. This leads to the development of the redness, 
warmth and oedema characteristic of inflamed tissue. Prostaglandins also play 
a vital role in the hyperalgesia that accompanies inflammation.
There are five naturally occurring prostaglandins PGD2, PGE2, PGF2a, PGI2 and 
TXA2 which activate the receptors DP, EP, FP, IP and TP respectively (Coleman 
et al., 1994) (see Table 1.4). PGE2 and PGI2 are the predominant 
prostaglandins generated in response to injury or inflammation. All prostanoids 
activate several second messenger pathways.
Prostaglandins are known to sensitise primary afferent fibres to some 
inflammatory mediators. Early animal studies showed that the sensitising
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effects of PGE2 could be mimicked with cAMP analogues (Ferreira and 
Nakamura, 1979). Previous work in animal studies showed that the co-injection 
of 5-HT and PGE2 enhanced the sensation of pain (Hong and Abbott, 1994). 
Recent studies have begun to elucidate the mechanisms underlying this 
sensitisation.
Table 1.4 - Classification of the prostaglandin receptor subtypes.
Receptor Activating Prostaglandin Transduction System
d2 pg d2 T cAMP via Gs (f AC)
EPi
pg e2
t  [Ca2+]
CM
Q
.
H
I t  cAMP via Gs (t AC)
CO
Q_LU I  cAMP via Gj inhibit AC
'M
'
Q_HI t  cAMP via Gs (t AC)
FP PGF2ct T PI + Ca via Gq
IP pgi2 T cAMP via Gs (T AC)
TP txa2 T PI turnover via Gq
AC -  adenylyl cyclase; PI inositol tris phosphate;
In cultured DRG neurones pre-treatment with PGE2 potentiated the bradykinin 
evoked increase in calcium in small diameter cells and increased the number of 
cells that responded to low concentrations of bradykinin (Smith et al., 2000).
The sensitising effects of PGE2 on the calcium response could also be mimicked 
by the membrane permeant cAMP analogue, dibutryl cAMP, and inhibited by 
H89, inhibitor of cAMP dependent protein kinase A (PKA) (Smith et al., 2000). 
Previous work by Nicolson (2000) demonstrated that when rat DRG neurones 
were pre-treated with PGE2 there was a significant increase in cAMP levels.
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Subsequently it was shown that pre-treatment of neurones with PGE2 could 
sensitise the response to histamine. Agents that inhibited cAMP production 
could block this sensitisation (Nicolson, 2000). Thus suggesting cAMP had a 
role in this sensitisation. However, it was not clear whether cAMP was acting 
directly or indirectly through the activation of PKA.
1.2.5- Activation of G protein linked receptors by inflammatory mediators
Noxious stimuli are detected by sensory receptors at peripheral nerve terminals 
of nociceptive fibres. Excitation causes a depolarisation of the nerve endings 
that elicits action potentials in the afferent fibres. Here DRG neurones have 
been used as a model for afferent fibre terminals (see section 1.3.0). They 
express various types of channels that can be directly activated including stretch 
activated channels and voltage gated channels. Additionally there are ligand- 
gated channels, where activation either leads to the activation of an ion channel 
directly linked to the receptor (e.g. 5-HT3, P2X, TRPV1) or activation of a G 
protein linked cascade.
Capsaicin binds to specific vanilloid receptor subtype 1, TRPV1, expressed on 
the peripheral terminals of nociceptive fibres (Caterina et a/., 1997). Additionally 
protons and noxious heat can activate the TRPV1 channel. Upon activation, a 
non-selective cation channel opens allowing the influx of calcium and sodium 
ions resulting in depolarisation of the cell. Action potentials are fired transmitting 
impulses to the CNS where pain and a burning sensation are perceived.
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Activation of G proteins can modulate channel function by direct binding to parts 
of the channel protein, or activate various second messenger transduction 
pathways (McKnight, 1991). A single activated receptor can activate multiple G 
protein molecules thus amplifying the ligand binding event. The G proteins are 
classified by their a subunits proteins of which four classes exist based on 
amino acid sequence comparison (Neer, 1995, Simon et al., 1991) (see Table 
1.5).
Table 1.5 -  Classes of G protein a subunits.
Class Members Effectors SignallingMolecules
as as, a0if t  adenylyl cyclase calcium channels
tcAM P  
t  Calcium 
Influx
at
av_i, ai-2,at_3
CtOA,OOB at11
at2 az
I  adenylyl cyclase, 
K+ channels, activate 
cGMP 
phosphodiesterase
I  cAMP
ctq/11
Oq,an,ai4,
(X15, «16
Phospholipase C |3 t  IP3
ai2 CC12, ai3
Regulate Na+/K+* 
exchange 
Cl' channels
The t  arrows indicate an increase while the I  arrow indicates a decrease.
PGE2 activates the G protein coupled EP receptors that can activate the 
adenylyl cyclase / cAMP pathway. The EP receptors activate different Ga 
subunits. EP2 and EP4 receptors activate the stimulatory Ga subunit thus 
increase adenylyl cyclase activity and hence increase cAMP levels. While 
activation of EP3 receptor coupled to the inhibitory Ga subunit leads to a
decrease in adenylyl cyclase activity and thus decreased cAMP levels. Cyclic 
AMP can activate protein kinases, which catalyses the phosphorylation of 
serinine and theorine residues in a variety of cellular proteins and hence 
regulates their function (Cohen, 1992).
Another pathway commonly utilised in DRG neurones is the inositol-1,4,5- 
trisphosphate(IP3)/ phospholipase C (PLC) cascade (Berridge and Irvine, 1989). 
Activated Hi receptors interact with a G protein coupled to the PLC /IP3 
transduction pathway to stimulate the mobilisation of calcium from IP3 sensitive 
internal stores and the activation of protein kinase C (PKC).
Almost all calcium signalling systems function by generating brief increases in 
intracellular calcium concentration [Ca2+],, which activate a variety of cellular 
activities such as channels (e.g. calcium gated potassium channel) and 
enzymes (e.g. calcium/calmodulin-dependent protein kinases) (Berridge, 1997, 
Berridge et al., 2003). The cell has two sources of calcium to initiate signalling: 
an infinite extracellular source and a finite intracellular source. The endoplasmic 
reticulum (ER) is a low capacity, high affinity calcium store while the 
mitochondria represent a high capacity, low affinity calcium store. Three main 
types of channels regulate calcium entry via the plasma membrane: voltage 
operated channels, store operated channels and receptor operated channels. 
Each class of channel has different kinetic properties with the voltage gated 
channels and receptor operated channels providing brief high intensity bursts of 
calcium while the store operated channels have small but sustained influx of
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calcium (Berridge, 1997). At least five major types of voltage activated calcium 
channels are expressed on sensory neurones (L, N, P/Q, T and R). These 
channels vary in their distribution and activation properties (Scroggs and Fox, 
1992, Scott et al,. 1991). The store operated channels main function is to 
replenish and maintain internal calcium stores (Berridge, 1995, Putney et al,. 
2001). When the internal stores are full little calcium enters through these 
channels. Immediately the stores content of calcium begins to decline calcium 
entry by capacitative calcium entry through these channels is promoted. Thus 
store-operated channels are controlled by the state of filling of the internal 
stores.
Internal stores play a crucial role in the generation and maintenance of calcium 
signals (Simpson et al., 1995, Berridge, 2002). Two channels mediate the 
release of calcium from the ER stores: the IP3 receptor gated channel and the 
ryanodine-gated channel (Bezprozvanny et al., 1991, Ehrlich et al., 1994). A 
critical feature of both receptor channels is their sensitivity to cytosolic calcium. 
The receptors gating the release of calcium from internal stores is controlled by 
calcium itself. This enables calcium released from one receptor to excite its 
neighbour thereby regulating a regenerative calcium wave further amplifying the 
signal. Both channels display positive and negative regulation by calcium 
(Berridge, 1997). The generation and dynamics of calcium signals in response to 
receptor activation by algogenic and pruritic mediators can be monitored using 
calcium indicator dyes such as Fura 2.
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1.3.0- Cultured sensory neurones as a model for the study of peripheral 
aspects of nociception.
Dorsal root ganglia contain the cell bodies of the primary afferent neurones that 
relay nociceptive and proprioceptive information from the periphery to the spinal 
cord. Due to the difficulty of studying peripheral nerve endings in situ, primary 
cultured DRG neurones have been commonly employed to investigate many 
aspects of sensory transduction. This approach assumes that the receptors 
they express are similar to those operating on the primary nerve endings. The 
following evidence shows that many of the characteristics of nociceptors are 
expressed by sensory neurones in culture:
• Immunostaining with an anti-neurofilament marker, RT97, showed that 
isolated small diameter dark DRG neurones were neurofilament poor 
(Lawson, 1979, Lawson et al., 1984, Perry et al., 1991). In vivo they 
give rise to the slow conducting unmyelinated C fibres and thinly 
myelinated A8 fibres (Harper and Lawson, 1985a) that are known to 
transmit nociceptive information.
• Specific algogenic agents activate DRG neurones maintained in vitro. 
Capsaicin, a known excitant of nociceptors, also evokes responses in 
a substantial proportion of these small diameter neurones. Moreover, 
low concentrations of bradykinin also activate some cells (Baccaglini 
and Hogan 1983).
• Prostaglandins can sensitise peripheral nociceptors to other noxious 
stimuli. In the presence of PGE2 a number of cultured sensory
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neurones showed a significant increase in the number of action 
potentials elicited by high potassium (Baccaglini and Hogan, 1983).
• Immunostaining has shown that many cultured DRG neurones contain 
substance P (Baccaglini and Hogan, 1983). In vivo substance P is 
released by capsaicin sensitive fibres and plays an important part in 
the induction of inflammation and pain (Holzer, 1988).
From this evidence we may conclude that cultured DRG neurones are useful for 
the study of aspects of sensory transduction mechanisms that are inaccessible 
to analysis in vivo, particularly the actions of algogens and pruritics.
The various types of DRG neurones differ in their intrinsic electrophysiological 
(Harper and Lawson, 1985b, Scroggs and Fox, 1992), cytochemical (Dodd et 
al., 1984, Schoenen et al., 1989) and anatomical properties (Lawson, 1979). 
Two thirds of the small DRG neurone population are characterised as 
nociceptive primary sensory cells (Perry and Lawson, 1991).
During development all small sensory neurones require nerve growth factor 
(NGF) for survival (Snider and McMahon, 1998). However, the sensitivity of 
these cells to neurotrophic factors changes as the animal matures. In cultures 
from adult animals the small diameter cells can be divided into two major 
subpopulations by their sensitivities to neurotropic factors (Averill et al., 1995, 
Michael et al., 1997, Molliver et al., 1997, Bennett et al., 1998). About 40-45% of 
the population express the NGF receptor tyrosine kinase A. These neurones
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coexpress CGRP and substance P. As noted earlier (p.22) both these 
neuropeptides are released from sensory fibres and are known initiators of 
inflammation and pain. As a further third of small diameter DRG neurones 
mature, they downregulate the expression of tyrosine kinase A receptors and 
increase the expression of another trophic factor receptor tyrosine kinase Ret, 
which is activated by glial cell derived neurotrophic factor (GDNF). Thus, these 
two populations can be differentiated by their sensitivity to GDNF. They also 
have distinct histochemistry, expressing the enzyme thiamine monophosphatase 
(TMP) and posses cell surface glycoconjugates that can be identified by binding 
of isolectin IB4 (Silverman and Kruger, 1990, Averill et al., 1995, Molliver et al., 
1997). Therefore, anti CGRP antibody and IB4 binding are generally regarded 
as markers for NGF and GDNF responsive primary sensory neurones.
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1.4.0- Aims of the study
In view of the evidence presented above concerning the possible role of 
histamine, 5-HT and ATP in itch and pain it is clearly important to characterise 
the effects of these agents on primary sensory neurones as a prelude to 
establishing their actions on the sensory nerve endings. Moreover, as some 
prostaglandins sensitise the skin to agents that evoke itch and pain, it is 
desirable to investigate the actions of these prostaglandins on the chemical 
sensitivity of the primary sensory neurones. To achieve these objectives this 
study has been focused on the following questions:
1. What population of sensory neurones express Hi receptors? Is receptor 
expression confined to cells that give rise to unmyelinated nerve fibres?
2. It is known that the response of sensory neurones to histamine can be 
sensitised by certain prostaglandins (specifically PGE2 and PGD2). It is 
also known that these prostaglandins act to raise intracellular cAMP 
levels in sensory neurones and that other interventions that raise cAMP 
also sensitise the sensory neurones to histamine. It is not, however, 
clear whether this effect of cAMP is mediated via protein kinase A or via 
some other pathway. Can the sensitisation be blocked by inhibitors of 
protein kinase A?
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3. What fraction of the sensory neurones population is sensitive to 5-HT, 
determined by its ability to raise intracellular Ca2+? Which receptors are 
involved in this response? Can the response be sensitised by 
prostaglandins in the same way as the responses to histamine? If so, 
what mechanisms are involved?
4. What fraction of the sensory neurones population is sensitive to ATP, 
judged by its ability to raise intracellular Ca2+? Which receptor subtypes 
are involved (P2X or P2Y)? A further, but unfulfilled, goal was to 
determine whether the response to ATP could be sensitised by 
prostaglandins.
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2.0 Material and Methods
2.1 Primary Culture of Adult Wistar rat DRG neurones
Coverslip Preparation
Coverslips were placed in a glass beaker, covered with 100% ethanol and gently 
agitated for 10 minutes making sure all coverslips were exposed to ethanol. The 
ethanol was poured off and the coverslips washed three times in a large volume 
of double distilled water then autoclaved in distilled water. Under sterile 
conditions the water was poured off and the coverslips were agitated gently in a 
solution of poly-L-ornithine (500 pg/ml). After an hour, the poly-L-ornithine was 
removed and the coverslips were washed three times in a large volume of sterile 
distilled water. The coverslips were divided and placed in small tubes 
(approximately 40 per tube) containing distilled water and stored in the fridge 
until required. Before cells were plated, the coverslips were placed in a 6 well 
plate (2 per well) and covered with a laminin solution (5pg/ml) for a few hours.
Dissection
Adult Wistar rats (approximately 200g) were killed by exposure to increasing 
concentrations of CO2 . An incision was first made at the caudal end of the 
spinal column which was then isolated and removed. The spinal column was 
then cut laterally down both sides (see Figure 2.1). The dorsal root ganglia 
located between the vertebrate were carefully dissected out from all levels of the 
spinal cord and placed in a 35 mm petri dish containing culture medium.
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Approximately forty ganglia were removed from the spinal cord. Where 
appropriate, the roots and processes were carefully removed from the ganglia 
and the cleaned ganglia were placed in a 35 mm petri dish containing culture 
medium and collagenase (type IV approx 463U/mg) then left to incubate for 3 
hours (37°C, 3% C 02).
Figure 2.1 -  Schematic representation of the DRG dissection procedure.
A) The removal of the spinal column allowing lateral cuts on each side to reveal 
the ganglia. B) Careful cutting of the ventral and dorsal processes free the 
ganglia. C) The cleaning (removal of ventral and dorsal processes) of ganglia. 
Adapted from (Lindsay ef a/., 1991).
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Dissociation
After incubation, the ganglia were transferred to a centrifuge tube and washed 
three times in culture medium to remove the collagenase. The ganglia were 
then resuspended in culture medium and the ganglia were mechanically broken 
apart by gentle tritruation through a flame polished short bore pasteur pipette 
approximately five times until a cloudy cell suspension was obtained. The 
remaining ganglia were allowed to settle, and then the supernatant was 
removed and retained in a centrifuge tube. This process was repeated until the 
cell to debris ratio in the suspension was low. The removal of the supernatant 
after each tritruation prevents mechanical damage to those cells that had 
already been dissociated. The collected supernatant was then centrifuged with 
13% bovine serum albumin at 1200 rpm for 12 minutes. After centrifugation the 
supernatant was removed and the cell pellets were gently resuspended in 
culture medium. The neurones were counted, with a typical yield given between
180,000-240,000 neurones per adult rat (-40 ganglia) then plated appropriately. 
Prior to plating, the solution in the 6 well plates was aspirated to remove the 
laminin solution. A drop of cell suspension was placed centrally on the 
coverslip. For calcium imaging experiments, cells were plated on the glass 
coverslips coated with poly-L-ornithine and laminin at a density of approximately 
0.1 X106 cells/coverslip. For immunohistochemistry cells were placed at a 
density of approximately 0.05x106 cells/coverslip.
The plated cells were left to incubate for one hour before the coverslips were 
flooded with culture medium containing NGF (200ng/ml). NGF is need for the
growth of neurones (Johnson et a/., 1980, Levi-Montalcini, 1987). Adult DRG 
can survive in culture without NGF. However, their sensitivity to some chemical 
mediators has been shown to depend on its presence e.g. capsaicin (Bevan and 
Winter, 1995). The cells were kept incubated (5% CO2, 37°C) for one to three 
days prior to experimentation. However, the majority of experiments were 
carried out on days one and two.
2.2 - Intracellular calcium imaging
Intracellular calcium changes in response to agonist stimulation were recorded 
from cultured DRG neurones loaded with the ratiometric dye Fura-2. The Fura-2 
dye was excited at 340 and 380 nm and the emitted fluorescence was collected 
via a cool charged coupled device (CCD) camera system (see page 49)
Dye Loading
Fura-2 is made cell permeant by the substitution of acetoxymethyl ester (AM) 
groups onto the dye. Although this form is not fluorescent, cells readily take up 
the acetoxymethyl ester. Once inside the cell an endogenous esterase removes 
the acetoxymethyl groups and the free dye is fully fluorescent again. The Fura- 
2AM was dissolved in 50 pg/pl of dimethyl sulfoxide (DMSO). To facilitate the 
loading of the cells, the detergent pluronic acid (0.01%), was then added to the 
DMSO/Fura solution and sonicated. The Fura-2AM ester and pluronic acid 
solution was added to the cell culture medium and sonicated. The cell culture 
medium was removed from the coverslip and replaced with the cell culture
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medium containing Fura-2AM (10 pM) solution. The cells were returned to the 
incubator (37°C, 5% CO2) for 40 minutes. After this time, the coverslip was 
washed with culture medium and incubated for a further 10 minutes.
The Setup
The plated coverslip was placed in a pre-greased chamber and a Teflon ring 
placed on top to form a tight seal (see Figure 2.2). An epi-fluorescence 
microscope (inverted Nikon Diaphot) with a fluor x20 objective lens was used. 
This objective lens allows adequate transmission of the excitation wavelength to 
the sample and collection of the fluorescent emission from the sample (see 
Figure 2.2). To obtain a bright field image of the sensory neurones, a phase 
contrast lens was used. The fluorescence excitation was provided by a 75W 
xenon short arc lamp, which provides an even spectrum of illumination through 
the near ultra violet (UV) and visible ranges. To prevent photolytic damage to 
the sample, neutral density filters were placed in the path of the UV light. Fura-2 
is a dual excitation dye so optical filters are needed to select the necessary 340 
nM and 380 nM excitation wavelengths. The filters were located in a rotating 
wheel controlled by the computer to allow synchronisation of filter changes with 
image frame acquisition. The filter wheel (Sutter Instruments) was located in the 
excitation path between the arc bulb housing and microscope (see Figure 2.2). 
A shutter was placed in the light path to prevent continuous radiation of the 
sample. A dichroic beam splitter was used to reflect the short wavelengths (340 
nM and 380 nM) that excite the preparation whilst allowing through the longer
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wavelengths (above 510 nM for Fura 2) emitted as fluorescence by the sample 
(see Figure 2.2). A 420nM barrier filter was used to block any scattered light 
from the excitation filters. The emitted fluorescence was collected by a cooled 
CCD camera (Digital Pixel, Brighton). A computer controlled the camera and 
filter wheel allowing rapid data acquisition and storage of data.
Cooled CCD Camera
The emitted fluorescence is collected by a cooled charged coupled device 
(CCD) camera. The image area (sensor) on the CCD camera is made up of 
rows of wells. When the CCD sensor is exposed to light the photons penetrate 
the silicon creating hole electron pairs. This charge is stored in each of the 
potential wells. As more photons fall on the device more electrons are liberated 
and stored. After a certain collection period the charge stored in the wells is 
read out into an electronic register. Each well is equivalent to a pixel. The 
signal produced is proportional to the amount of charge from each pixel. The 
electron charge is then amplified, sampled and digitised before being displayed 
and stored. The final image was produced by the balance of intensities of the 
pixels.
Experiment Protocol
After loading the cells with Fura-2, the coverslip was placed in a pre-greased 
chamber and a Teflon ring placed on top to form a tight seal (see Figure 2.2). 
The well was then filled with Na+ locke solution (200/400 pi). The chamber was
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placed on the microscope stage and a suitable field of cells was selected. A 
typical field would contain ten to fifteen neurones. A brightfield image of this 
field was taken and saved to allow cell identification at the end of the 
experiment. Subsequently the experiment was carried out in the dark to 
minimise the signal contamination by ambient light. First, a two frame grab was 
acquired. A grab consists of one frame at 340 nM excitation and one frame at 
380 nM excitation with a interval of five seconds between images. The 
collection time for the 340 nM excitation was three times longer than the time for 
380 nM excitation. This initial image acquisition was carried out to check that 
the signal at each wavelength was neither saturated nor too dim. Ideally the 
signal was at least three times the value of the background. Neutral density 
filters with limited transmittance and alteration of the collection time were used to 
optimise the signal to background ratio. The image pairs were acquired every 
five seconds and stored on a computer. Subsequently, the ratio of the 340/380 
images could be calculated to give an indication of the intracellular free calcium 
concentration during the course of the experiment. At the end of each 
experiment the cells were lysed with 0.1% triton to discharge the cytosolic dye. 
A short sequence of images were taken for the background signal which was 
due partly to light scatter and partly to dye bound to intracellular constituents.
After the cells were loaded, a suitable field was found and optimal signals 
obtained. A typical run of 40-70 frames was then acquired (see Figure 2.3). 
The agonist solutions were added in equal volume to the bath fluid to give the 
required agonist concentration. This gave instantaneous mixing. The agonist
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Figure 2.2 -  Schematic representation of the experimental apparatus for 
fluorescence measurements.
The Fura-2 loaded cells plated on a 16 mm coverslip were mounted on the 
stage of an inverted epi-fluorescence microscope. The filter wheel rotates 
between the 340 nM and 380 nM filters to excite the Fura-2. Fluorescent 
emissions above 420 nM passed through the dichroic mirror and were collected 
by the CCD camera.
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solutions were pipetted into the bath at the appropriate frame (e.g. frame 45). 
Ten frames were acquired prior to agonist stimulation to allow the calculation of 
the basal level of calcium. The cells were washed by draining the chamber and 
replacing the fluid in the bath with a fresh solution. In some protocols the 
neurones were pre-treated with antagonists or sensitising agents prior to the 
agonist challenge. The pre-treatment either occurred for a short period (e.g. 
45s) within the same sequence of images or, for longer periods in a separate 
sequence. This was done to assess whether the added agent evoked a 
response in the cell or affected basal calcium levels. At the end of all 
experiments, the cells were challenged with 50 mM potassium to check cell 
viability and identity. Healthy cells respond with a large rise in intracellular 
calcium upon stimulation with high potassium (see Figure 2.4). Each image 
sequence was saved at the end of the experiment. All experiments were carried 
out at room temperature (20-24°C).
Data Analysis
The images were saved to magneto-optical disk as four dimensional image 
sequences. They were subsequently analysed offline using Kinetic imaging 
LUCIDA (version 3.5) and Microcal Origin (version 6). First, the image 
sequences were divided into their respective 340 nM and 380 nM wavelengths 
and the background for each wavelength was subtracted. The brightest image 
in the stack of the 340 nM wavelengths was thresholded to give a mask. This 
mask was then used to set the pixels in the background to zero. The masked
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Figure 2.3 -  Experimental protocols for the addition of agonists to sensory 
neurones.
The top line diagram shows the addition and duration of exposure to the agonist. 
The bottom line diagram shows a protocol for the addition of a sensitising agent 
before the agonist, in this case histamine. The addition of high potassium (50 
mM) in both experiments was to test the viability and identity of the cells.
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340 nM image sequence was then divided by the subtracted 380 nM image to 
give the final ratio image. The cells of interest were marked as regions of 
interest and the ratio values plotted as a function of time. To be considered 
healthy, the cells should have a stable basal 340/380 ratio level between 0.8- 
1.50 and the cells should respond to a challenge of high potassium with a large 
increase in [Ca2+]j. In the early experiments the basal 340/380 ratio level was 
slightly lower around 0.6-1.3 due to a difference in the optics of the system. For 
each individual cell, the mean basal level ± standard deviation was determined 
for the frames before the addition of any agonist. The classification of a positive 
response to any agonist was determined as a rise in intracellular calcium, which 
was greater than two standard deviations above the mean basal level for that 
cell. Figure 2.4 shows a typical range of calcium responses elicited by DRG 
neurones, which have been pre-treated with PGE2 then challenged with 10 pM 
5-HT. The responses of cells 1 and 3 show a rise in intracellular calcium, 
greater than 2 standard deviations above their baseline, upon stimulation with 5- 
HT and high potassium. Although there is a slight rise in the intracellular 
calcium response of cell 2 upon the addition of 5-HT, the increase is not greater 
than 2 standard deviations above its baseline. Thus, only cells 1 and 3 would be 
counted as a positive response in this study. The time course of cell 5 shows no 
response to the challenge with 5-HT however a large rise in intracellular calcium 
is evoked upon the addition of high potassium. Thus, cell 5 is considered viable 
and classified in this study as a non-responder to 5-HT (i.e. insensitive to 5-HT). 
Any cell, which does not respond to the agonist or high potassium challenge,
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was considered to be unhealthy or non neuronal and excluded from the study 
(e.g. Cell 4 in Figure 2.4).
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Figure 2.4 -  Typical range of calcium responses evoked by neurones, which 
have been pre-treated with PGE2 then stimulated with 5-HT and high potassium.
To study the effects of various agonists on the behaviour of the population of 
neurones, individual responses acquired by the same protocols were pooled and 
a mean ratio value ± the standard error of the mean (s.e.m.) was determined. 
Only the responding cells were included in the mean plots. The individual 
patterns of cells responses to the agonists were also examined before plotting
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the mean calcium responses. Note that the variation in the individual patterns 
can be masked when plotting the mean ± s.e.m. The variance in the individual 
calcium responses would be reflected if the mean calcium response were 
plotted ± standard deviation. However, this study is primarily interested in the 
average behaviour of the population of neurones.
Statistical Analysis
The number of cells responding for each treatment were pooled and expressed 
as a percentage of the total number of cells tested for that particular treatment. 
Fisher’s exact test was employed to determine any statistical differences in the 
number of cells responding to one treatment in comparison to another treatment. 
This is a rigorous statistical test to employ when the sample numbers are 
relatively small. The amplitudes of the calcium responses evoked by neurones 
upon stimulation by particular agonists were compared using an unpaired Welch 
corrected t test.
Calibration of intracellular calcium
Experiments were carried out to allow the calibration of the 340/380 ratio to give 
an estimation of the free calcium concentration in the cells. Initially the cells 
were permeabilised with an ionophore, ionomycin (2 ^M), in a medium 
containing excess calcium (3 mM). This provides values for the maximum ratio 
at the 340 nM wavelength and a minimum value at the 380 nM wavelength. The 
cells were washed with a solution containing 0 mM calcium, 10 mM EGTA and
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ionomycin which gives the minimum ratio value. After ten minutes the cells were 
again challenged with the high calcium solution (see Figure 2.5).
The changes in intracellular calcium were calibrated using the following 
equation (Grynkiewicz etal., 1985).
[Ca2+]i = Kd [ ( R-Rmin ) /  ( Rmax-R )]( SC / Sb2 )
where R is the measured ratio of interest. The Rmin and Rmax are the ratios 
recorded with the zero and high calcium solution respectively. Sf2 and Sb2 are 
the signals at 380 nM wavelength in the zero and high calcium solutions 
respectively. K<j is the dissociation constant of the indicator and reflects the 
indicator’s affinity for calcium. The Kd value used for Fura 2 was 224 nM 
(Grynkiewicz et a/., 1985). The values obtained in the sensory neurones were 
Rmin 1.03 ± 0.08 and Rmax 5.85 ± 0.59. The Sf2/Sb2 ratio was calculated as 3.26 
± 0.25. The average basal ratio in the sample (n=6) of DRG neurones was 1.26 
± 0.08 which according to the above equation would equate approximately to a 
basal intracellular calcium concentration of 40 nM. However, these calculated 
values are considerably lower in comparison to the values found previously in 
rat sensory neurones using the same setup (Nicolson, 2000). The possible 
reasons for these low values are discussed in section 4.1. Table 2.1 gives an 
indication of the relationship between the 340/380 ratio and the intracellular 
calcium concentration.
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Table 2.1 -  The variation in 340/380 ratio correlates to the concentration of
free intracellular calcium.
340/380
Ratio
Free Calcium 
Concentration 
~nM
1.2 25
1.4 60
1.6 100
1.8 140
2.0 180
2.5 320
3.0 500
3.5 760
The values used to calculate the free calcium concentration were: Kd -  224 nM, Sf2/Sfc>2 
- 3.26, Rmin -1.03 and Rma* - 5.85.
3mM Ca**+ Ca^Free + EGTA 3mM Ca* +
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Figure 2.5 -  A typical pattern for the ratio changes seen when a cell 
permeabilised with ionomycin and subsequently challenged with solutions 
containing a high calcium concentration followed by a solution nominally calcium 
free.
59
2.3 - Immunohistochemistry
Antibodies can be used as histochemical reagents when linked to suitable 
markers. Of the many dyes tested as markers, only fluorescent dyes provide 
the required sensitivity. The markers must not interfere with the antigen- 
antibody interaction, be stable upon storage and the peak of the emission 
spectra should permit its separation from the exciting wavelength. The excitation 
and emission wavelengths for the markers used in fluorescence immunostaining 
are given in Table 2.2.
Table 2.2 - The properties of the fluorescent markers used.
Fluorphore
Excitation Wavelength 
(nM)
Emission Wavelength 
(nM)
FITC 493 519
TRITC 550 573
AMCA 345 425
Immunostaining was performed on sections cut from the dorsal root ganglia 
isolated from lumbar segments 4 and 5 and on dissociated neurones.
Fixation and tissue preparation
Prior to immunohistochemistry the dissociated cultured cells and sections were 
fixed. The culture medium was removed from the plated coverslips, which were 
then covered in 4% paraformaldehyde in 0.1M phosphate buffer and left for
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thirty minutes. The coverslips were washed in phosphate saline buffer and 
placed in a humidified chamber.
The fixed dorsal root ganglia were cut in sections 10 pm thick using a Bright 
cryostat and were thaw mounted onto poly-L-lysine coated slides. The slides 
were labelled and the sections were circled with a PAP pen. This prevents the 
immuno reagents dispersing to the edge of the slides. The slides were then 
placed in a humidified chamber at room temperature.
The sections and dissociated cells were blocked with 10% normal donkey serum 
for one hour. After an hour the excess solution was simply drained off and the 
primary antibody was applied immediately. Both the sections and dissociated 
cells were incubated overnight in the combinations of primary antibodies. Table 
2.3 shows the primary antibodies used and their dilutions. All antibodies were 
diluted to the appropriate concentration in antibody buffer (see Appendix 6.1 for 
composition). After incubation, the sections were washed three times, for ten 
minutes each time, in phosphate saline buffer. Sections and dissociated cells 
were then incubated in the appropriate combinations of secondary antibodies 
diluted in antibody buffer, for one to two hours. Secondary antibodies were 
raised against the IgG of the species providing the primary antibody and then 
conjugated to a fluorescent marker.
The sections were washed three times, for ten minutes each time, in phosphate 
saline buffer. It is important not to allow the sections to dry out at any point. 
After the final wash the sections were prepared for the microscope. A drop of
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mounting solution was placed on the sections and they were covered with a 
coverslip and sealed with nail polish. The cells plated on the 16 mm coverslips 
were mounted to a microscope slide and sealed with nail polish. All 
immunostaining took place at room temperature.
Table 2.3 - The concentrations of the primary and secondary antibodies.
Primary
Antibodies
Dilution Fluorescent
Marker
Dilution
N52 1:10,000 AMCA 1:200
IB4 (lectin) 1:200 TRITC 1:200
CGRP 1:100 TRITC 1:200
Hi receptor 1:100 FITC 1:200
The sources of all antibodies are given in appendix 6.1. The chemical names for the 
fluorescent markers are given in the abbreviations.
Images were collected using Hamamatsu CCD camera and image Pro Plus 
software (Media Cybernetics, Silver Spring MD). The fluorescent preparations 
were examined as soon as possible and stored in the dark at 4°C.
Analysis
There are a number of different ways to quantify immunostaining, however all 
methods have various drawbacks. In these preliminary experiments the 
intensity of staining has been judged by eye. For each set of experiments the 
total number of cells has been counted. A neurone was judged to be positive for 
a specific stain when there was a clear difference in the intensities of the stained 
cell from the background. The neurones that stained positive for each antibody 
were counted. This study also quantified the number of neurones which
expressed more than one marker. This technique does introduce the problem of 
bias and is limited by the ability of the eye to determine shades of colour.
If this work was continued, the staining would be quantified by the intensity 
method. Here the intensity of the non-specific staining (background) is 
determined from a number of sections that are stained with only the secondary 
antibody. The intensity of the negative cells is counted and the mean 
background count is obtained. In the remaining sections stained with primary 
and secondary antibodies, cells are deemed positive if their fluorescent count is 
greater than two standard deviations above the background count. Problems 
can occur with this technique even when the secondary antibody is very clean, 
i.e. there is a very low background count. This situation often leads to an 
underestimation of the background count and a greater number of cells will 
appear to be positive. Nevertheless, this technique is a less subjective 
approach and thus limits bias.
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2.4 - Western Blotting
In 1975 Southern introduced a technique which allowed the identification of 
specific DNA fragments. These fragments had been resolved by gel 
electrophoresis then transferred to a nitrocellulose membrane. This technique, 
known as southern blotting, proved to be fundamental to molecular biology. 
Adaptation of southern blotting, allowed the development of techniques to 
analyse RNA (northern blotting) and proteins (western blotting). Western 
blotting uses electrophoresis to separate proteins, which can be immobilised 
onto a matrix and analysed using various probes including antibodies. The 
following method describes the use of a gradient SDS-PAGE gel. 
Electrophoresis in the presence of SDS separates proteins almost exclusively 
on the basis of mass with smaller polypeptides migrating more rapidly. Gradient 
SDS page gel provides superior resolution of different bands in the gel. In this 
study western blotting was used to authenticate the Hi receptor antibody. A 
brief overview of the technique is given below but for greater detail see 
Appendix 6.2.
Protocol
The sample preparation is critical to the running of the gel. The sample proteins 
need to be solubilised, denatured and disaggregated before loading on the gel. 
DRG neurones were dissected from male Wistar rats as previously described 
(see Section 2.1). The DRG neurones were suspended in lysis buffer and 
homogenised using a clean micropestle. The sample was spun and the
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supernatant was removed to a fresh eppendorf where loading buffer was added. 
The bromophenol blue tracking dye in the loading buffer migrates with the 
sample allowing the progress of the sample to be monitored during 
electrophoresis. The two gels were assembled in the gel apparatus and a small 
volume of running buffer was poured into the chamber between gels with the 
remaining buffer poured into the external tank. Equal volumes of sample (30 pi 
-  50 pi) were added to each well. Pre-stained molecular weight markers were 
then loaded into the reference lanes. The gel was run at a constant 100V for
1.5-2 hours.
The gel was then transferred to nitrocellulose membrane at a constant 0.41 A for
1.5-2 hours. The transfer apparatus was dismantled and the membrane was 
placed protein side up in a small tray containing 10% milk solution, covered with 
cling film and left on a rocker for one hour at room temperature. The milk blocks 
the non-specific binding sites on the membrane. After an hour the 10 % milk 
solution was replaced with 5% milk solution containing the HiR antibody at a 
dilution of 5 pg/ml, covered and left on a rocker overnight at 4°C. The 
membrane was then washed with tris buffered saline tween (TBS-T) buffer then 
returned to the tray which contained anti rabbit secondary antibody at a dilution 
of 1:2000 in 5% milk solution, covered and place on a rocker at room 
temperature for 1-2 hours.
65
The chemiluminscent agents were mixed together and pipetted onto the blot for 
two to three minutes. The excess solution was removed and the blot was 
covered in cling film. In the dark room the blot was exposed to x-ray film for one 
to two minutes then developed. The bands on the x-ray film were compared 
with the molecular weight markers on the blot to give an estimation of the 
molecular weight of protein identified by the bands on the detecting film.
The blot illustrates that the affinity purified anti Hi receptor antibody recognised 
a protein band with an apparent mass between 47.4 and 60.7 kDA (see Figure 
2.6). This is consistent with previous studies that revealed a molecular mass of 
56 KDa for the Hi receptor protein in rat, mouse and guinea pig (Ruat and 
Schwartz 1989, Ruat et a/., 1988). The other bands that appear on the blot all 
have an apparent mass greater than that of the Hi receptor. This suggests that 
these are complexes e.g. the receptor plus a precursor.
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47.4 kD — ►
Figure 2.6 -  Western blot identifying a band that corresponds to the 
apparent molecular mass of the H-i receptor.
The arrow on the right of figure identifies the band which is thought to represent 
the Hi receptor.
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3.0 -  RESULTS
3.1 - Dorsal Root Ganglion Morphology
The cell bodies of the primary afferent fibres lie in the dorsal root ganglia. As 
discussed earlier (section 1.3.0, p39), DRG neurones have often been used 
as a model for the investigation of the transduction mechanisms of the 
peripheral afferent fibres. This approach has been followed here and this 
section is concerned with the morphological characterisation of these cells. 
Figure 3.1 shows a typical field of DRG neurones at day 1 in culture.
Neurones were identified by their appearance and response to a high K+ 
stimulus. Under phase contrast optics, healthy viable neurones have a 
characteristic granular appearance and are surrounded by a bright halo. 
Satellite cells could be distinguished by their phase dark appearance and the 
presence of many fine processes. As the DRG neurones were plated at low 
density it was relatively easy to identify individual neurones. Any cells that 
did not look healthy or raised doubt as to their neuronal nature (e.g. did not 
depolarise upon stimulation with high K+) were not included in this study. 
Calcium imaging experiments were performed after one to three days in vitro. 
At this time neurite growth from the DRG neurones was limited and there was 
little overcrowding of non-neuronal cells.
The diameter of the cultured DRG neurones typically ranged from 10 - 30 pm 
(see Figure 3.2). The majority of neurones had a diameter in the range 12- 
17.9 pm (63%, n=118/187) and the mean diameter was 15.41 ± 0.27 pm. 
The culture technique resulted in a high yield of small diameter DRG
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Figure 3.1 - A typical field of cultured DRG neurones at day 1 in culture.
The dorsal root ganglion neurones appear phase dark and are surrounded by a 
bright halo. The scale bar represents 20 pm.
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Figure 3.2 - The distribution of neuronal diameters in the sample.
The histogram is derived from a sample of neurones (n=187) used for the 
calcium imaging experiments reported here.
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neurones. Thus, most of the neurones from which recordings were obtained 
would probably give rise to A8 and C fibres.
3.2 -  Sensitivity of sensory neurones to histamine.
Histamine is now well established as a pruritic agent and is commonly 
employed in experimental models of itch (see Section 1.2.1 p25). Previous 
work in this laboratory by Nicolson (2000) demonstrated that histamine 
evoked a rise in [Ca2+]j in a sub-population of rat DRG neurones and showed 
that this response was mediated by the Hi receptor. This response could be 
sensitised by PGE2 via a mechanism that was shown to depend on an 
increase in cAMP. Exactly how the cAMP induced sensitisation was not 
resolved. This work was carried out on Sprague Dawley rats and not Wistar 
rats as used in these experiments.
Before investigating the mechanism of this sensitisation, the histamine dose 
response curve was repeated. The proportion of sensory neurones 
responding to histamine increased from 4% to 32% in Wistar rats and 1 % to 
35% in Sprague Dawley rats as the concentration rose from 10 pM to 10 mM 
histamine. The difference between the two strains was evident as a slight 
rightward shift in the dose-response curve (see Figure 3.3). The rightward 
shift was found not to be statistically significant using Fisher’s exact test. 
Thus, the sensory neurones of Wistar rats are marginally less sensitive to 
histamine than those of Sprague Dawley rats.
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As the sensitivity of cells to some agonists (e.g. capsaicin) is known to be 
affected by time in culture (Bevan and Winter, 1995). The sensitivity of DRG 
neurones to histamine on successive days was explored. The proportion of 
cells responding to 10 mM histamine on day 1 (n=48/145) was not 
significantly different to the number of cells responding on day 2 (n=26/88, 
p=0.66). Moreover, the proportion of cells responding to 100 pM histamine 
on day 1 (30/235) was similar to the number responding on day 2 (n=22/109; 
p=0.55) and on day 3 (n=11/118; p=0.38). These findings are consistent with 
those of Nicolson (2000) who showed that the proportion of cells responding 
to 100 pM histamine did not change significantly over the course of six days. 
Thus, the length of time neurones were maintained in culture did not appear 
to affect their sensitivity to histamine.
Variation in individual sensory neurones responses to histamine
Individual sensory neurones showed considerable variation in the time 
course and amplitude of the [Ca2+]j change in response to histamine (see 
Figure 3.4). Figure 3.4A shows a bright field image of a typical field of DRG 
neurones. In the field shown, four cells of interest have been labelled. The 
top three panels of Figure 3.4B show the same field, as pseudocolour 
images, at various time points during the experiment. Figure 3.4C shows the 
time course of the individual [Ca2+]j responses in detail for each cell. At rest, 
0 s, the blue colour of the cells illustrated that all four cells had low levels of 
intracellular calcium. There was very little fluctuation in basal calcium levels 
of these cells, shown by the straight baselines in Figure 3.4C.
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Figure 3.3 -  Histamine sensitivity of sensory neurones varies 
marginally between strains of rat.
The graph shows the percentage of sensory neurones responding to 
histamine as a function of concentration. The percentage of neurones 
responding increases progressively with histamine concentration. The curves 
were fitted to the Hill equation giving a slope of 0.59 for Sprague Dawley and 
0.46 for Wistar. (Sprague Dawley data from Nicolson 2000)
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However, upon the addition of 10 mM histamine, at 45 s, a large rise in 
intracellular calcium was evoked in cells 1 and 4 (from ratio values of 0.88 
and 0.94 respectively to peak values of 2.42 and 2.19). In the pseudocolour 
images this rise in calcium is shown by a change in the colour of cells 
towards yellow/red, which signify high levels of [Ca2+]j. Cell 3 has had a 
moderate rise in [Ca2+]j while cell 2 showed a marginal change in [Ca2+]j of 
0.12 ratio units. By the end of the experiment, the [Ca2+]j of cells 1,2 and 4 
have returned to near resting levels while in cell 3, there was little decay of 
[Ca2+],.
Examination of the responses evoked by individual neurones to 10 mM 
histamine, showed three distinct patterns (see Figure 3.5A, B and C): In a 
small number (n=6/74) of cells the response was brief and of low amplitude 
(Figure 3.5A). In around a quarter of the neurones responding to histamine, 
the rise in intracellular calcium peaked within 20 s, and decayed slowly 
(Figure 3.5B). However, the majority of cells (50/74) responding to 10 mM 
histamine showed a response pattern similar to Figure 3.5 C. Upon 
stimulation there was a large increase in intracellular calcium reaching a 
peak within 15 s. The response decayed in a biphasic manner with an initial 
period of rapid decay followed by a slow decline. The profile of the mean 
response to 10 mM histamine (Figure 3.5 D) was consistent with the large 
number of responding cells that displayed a response pattern similar to 
Figure 3.5 C. The proportion of cells showing these individual patterns did 
not change between day 1 and day 2.
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Figure 3.4 -  Variation in [Ca2+]i signal from individual sensory neurones 
upon stimulation with 10 mM histamine.
Panel A shows a brightfield image of a typical field of DRG neurones. Four 
cells have been labelled. Panel B shows the same field of cells, as 
pseudocolour images, at certain time points during the experiment. Panel C  
shows the time course of the change in [Ca2+]j in the four cells upon the 
addition of 10 mM histamine. The black bar shows the presence of 
histamine. The scale bar in Panel A and B represents 20 pm. The spectrum 
wedge (Panel D) indicates the relationship of the pseudocolour images to the 
Fura-2 ratio.
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Figure 3.5 -  The variation in individual neurones responses to 10 mM 
Histamine.
Panels A, B and C show typical examples of the three distinct calcium 
response patterns seen upon stimulation with 10 mM Histamine. The n value 
gives the number of cells that respond with a similar pattern. Panel D shows 
the mean calcium response profile for all the responders together with the 
s.e.m. The black line indicates the presence of histamine.
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Effect of concentration on the time course of the [Ca2+]i response to 
histamine.
The time course of the mean [Ca2+]j response varied with the applied 
histamine concentration. Low histamine concentrations (10 pM -  1 mM) 
evoked a rise in [Ca2+J that reached a peak within 20 s. The response then 
very slowly decayed towards baseline (see Figure 3.6 A and B). The 
application of the highest histamine concentration (10 mM) evoked a rapid 
rise in 340/380 ratio from a baseline value of 0.67± 0.01 to reach a peak 
value of 1.38 ± 0.09 (n=74/233) within 15 s. Following the peak this 
response then decayed towards baseline, with a time constant of 
approximately 35 s, (see Figure 3.6C). There was only a marginal change in 
the time taken to reach a peak with increased histamine concentrations yet 
the amplitude of the response to histamine more than doubled from 31% to 
105% at the highest concentration (see Table 3.1).
Table 3.1 -  Time to peak and amplitude of the [Ca2+]j response to 
histamine.
Histamine
concentrations
Time to Peak (s)
Amplitude
%(AR/R)
n =
100 pM 20 31 63/563
1 mM 20 23 19/96
10 mM 15 105 74/233
n refers to the number of cells responding to histamine out of the total 
number of cells tested.
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Figure 3.6 - The [Ca24]; responses to histamine in sensory neurones.
The mean response of histamine sensitive neurones to (A) 100 pM histamine 
(B) to 1 mM histamine and (C) to 10 mM histamine.
Histamine was applied at 45 s for the duration of the experiment as indicated 
by the black bar.
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3.3 - PGE2 induced sensitisation of sensory neurones to 
histamine.
Sensitisation is a key feature of both the itch and pain sensations. Pre­
treatment with PGE2 is known to enhance the sensitivity of sensory neurones 
to some inflammatory mediators for example bradykinin (Nicol and Cui, 1994, 
Smith et a/., 2000). Furthermore, Nicolson et a/., (2002) showed that PGE2 
enhanced the sensitivity of sensory neurones to histamine. This sensitisation 
was shown to involve cAMP (see Section 4.4, p. 167) as Nicolson (2000) also 
reported a PGE2 evoked elevation in cAMP in DRG neurones which could be 
mimicked by forskolin (see Figure 3.7).
Due to the slight difference in the dose response curve for Wistar rats and 
Sprague Dawley rats it was necessary to test whether this sensitisation could 
be shown in the Wistar strain. The sensory neurones were pre-treated for 5 
minutes with 10 pM forskolin then challenged with 300 pM histamine. The 
application of forskolin alone did not elicit any response in the neurones and 
the test concentration of histamine (300 pM) evoked a response in only 13% 
(n=29/217) of neurones. Five minutes pre-treatment with 10 pM forskolin 
prior to the histamine challenge significantly increased the proportion of 
sensory neurones responding to 18% (n=42/230 p= 0.032) (see Figure 3.8).
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Figure 3.7 - Effect of PGE2 and forskolin on [cAMP]i levels in sensory 
neurones. (Data from Nicolson, 2000).
The cAMP concentration is expressed in relation of the total protein content. 
The application of (A) PGE2 and (B) forskolin (for 45 seconds and 5 minutes) 
produced a significant (p=0.004, p<0.0001, p<0.0001 respectively) increase 
in intracellular cAMP concentration which is illustrated by the asterisks. Error 
bars are s.e.m.
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Note that the histamine-evoked calcium response following forskolin 
treatment was similar to that obtained to histamine alone (see Figure 3.9). 
Thus, the forskolin-induced sensitisation of the histamine response seen by 
Nicolson (2000) in Sprague Dawley rats could be reproduced in the Wistar 
rat strain.
PGE2 induced sensitisation of the bradykinin response is known to be 
mediated by cAMP dependent protein kinase A (PKA) (Smith et al,. 2000). 
Preliminary work by Nicolson (2000) showed that pre-treatment of cells with 
PKI and H89 (selective inhibitors of PKA) produced a slight decrease in the 
PGE2-induced sensitisation of the histamine response. This raised the 
possibility that the cAMP induced sensitisation was mediated by PKA. To 
investigate this, DRG neurones were pre-treated with H89 before treatment 
with forskolin and stimulation with histamine. When the neurones were pre­
treated for 15 minutes with 300 nM H89 the fraction responding to 300 pM 
histamine fell from 18% (n=42/230) to 8% (n=14/168 p=0.005) (see Figure 
3.8). This suggests that the forskolin-induced sensitisation (and therefore the 
cAMP induced sensitisation) of the histamine response is mediated by PKA.
The pre-treatment with H89 did not affect the time course or amplitude of 
calcium responses evoked by cells stimulated with histamine alone or with 
histamine following forskolin pre-treatment (not shown). When cells were 
treated with H89 (300 nM) for 15 minutes, before the histamine challenge 
(300 pM), the proportion of neurones showing a rise in [Ca2+]i was reduced 
from 13% (n=29/217) to 8% (n=10/130 p=0.166) (see Figure 3.8).
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Figure 3.8 -  PKA inhibitor, H89, blocks the forskolin-induced 
sensitisation of the histamine response.
The bar chart shows the percentage of cells responding to 300 pM histamine 
after pre-treatment with 10 pM forskolin, 10 pM forskolin and 300 nM H89, 
and 300 nM H89 alone. (+) signifies a significant increase with respect to the 
control in the proportion of cells responding to histamine after pre-treatment 
with forskolin (p=0.032). The increase observed with the forskolin pre- 
treatment was significantly reduced (p=0.005) when the cells were pre­
treated with forskolin and H89 (indicated by asterisk).
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Figure 3.9 -  The effect of forskolin on the mean calcium response 
evoked by neurones upon stimulation with 300 pM Histamine.
The profile of the mean calcium response obtained in histamine sensitive 
cells after pre-treatment with forskolin is similar to the profile of the mean 
calcium response obtained to histamine alone. The black line indicates the 
presence of histamine.
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3.4 -  Chemical and immunological characterisation of the 
histamine sensitive neurones.
The expression of the Hi receptor in DRG neurones
Although this study has focussed on the histamine sensitivity of isolated 
neurones, it is of some interest to match their properties to those of DRG 
neurones in situ. This can be achieved by the use of neuronal markers (see 
Section 1.3.0, p39). In this study three markers were used in addition to an 
antibody to the Hi receptor: N52 antibody, calcitonin gene related peptide 
(CGRP) antibody and isolectin B4 (IB4). The N52 antibody labels neurones 
that are rich in neurofilament, which by and large are the myelinated fibres. 
Thus, this marker will predominantly label DRG neurones that are likely to 
give rise to myelinated fibres. As discussed in section 1.3.0, the nociceptive 
primary afferent neurones can be divided into two subgroups, which can be 
distinguished by CGRP antibody and IB4 binding. The CGRP antibody 
identifies neurones that would give rise to peptidergic C fibres, which are 
NGF responsive. While IB4 binds to neurones that would give rise to 
non-peptidergic C fibres, which are GDNF responsive. An Hi receptor 
antibody was used to identify the population of DRG neurones expressing the 
Hi receptor. Note that the identification of Hi receptor by the antibody does 
not necessarily mean that the receptors are functional.
Dissociated and sectioned DRG neurones were triple labelled with anti-Hi 
receptor, anti-N52 and either with anti-CGRP or IB4. Immunolabelled 
neurones were evenly distributed throughout the cultures and were easily
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distinguishable from unlabelled neurones. In control cells, where no primary 
antibody was applied, no staining was observed. The staining showed a 
degree of specificity as not all cells were labelled. As mentioned in section 
2.3 these are preliminary experiments and thus the observations discussed 
below are based on the limited data available.
In the dissociated neurones, positive staining for each of the antibodies was 
seen in a proportion of cells (see Figure 3.10). The merged images and bar 
chart (Figure 3.10 A, B and D) show that around half of the neurones which 
are N52 positive also show positive staining for Hi receptor. Although most 
small neurones give rise to C fibres some give rise to the thinly myelinated 
A6 fibres. This pattern of labelling is consistent with previous findings 
showing that some A5 fibres are histamine sensitive (Handwerker et al,. 
1987). In Figure 3.10A and D a small fraction of neurones stain with the anti- 
CGRP antibody which all co-localise with Hi antibody staining. Moreover, 
Figure 3.1 OB and D show that a quarter of the neurones that bind IB4 co­
express the HiR antibody. Both these markers (CGRP and IB4) are known to 
label unmyelinated fibres. Additionally this data suggests that Hi receptors 
are expressed on DRG neurones that may give rise to nociceptive fibres. 
However, in each of the triple labelling experiments there was a small 
population of neurones that only showed positive staining for the Hi receptor 
antibody (see Figure 3.10).
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Figure 3.10 -  The expression of Hi receptor in rat DRG neurones.
(A) Dissociated DRG neurones were stained with anti-Hi receptor antibody, 
anti-N52 and IB4. The merged image shows co-localisation of Hi receptor 
expressing neurones primarily with IB4 (neurones in yellow in the merged panel). 
The merged image also shows neurones with a turquoise colour suggesting that 
these neurones express both the Hi receptor and N52.
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Figure 3.10 B The dissociated neurones were stained for the Hi receptor, 
CGRP and N52. The three separate images show that there is positive staining 
for each of the antibodies. The merge image shows co-localisation of Hi 
receptor expressing neurones with CGRP (yellow appearance). The one 
turquoise cell in the merged image shows the co-localisation of the Hi receptor 
expressing neurones with N52.
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Figure 3.10 C The DRG section has been stained with anti Hi receptor, IB4 and 
anti N52. In the merged image the cells with a yellow appearance show the co­
localisation of neurones expressing Hi receptor and IB4. The co-localisation of 
neurones expressing Hi receptor and N52 is illustrated by the two cells with 
turquoise appearance.
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Figure 3.10 D -  Co-localisation of the neuronal markers and the HiR 
expressing neurones.
Hi receptor appears to be expressed on neurones that give rise to both 
unmyelinated and myelinated fibres. Note that these are preliminary 
experiments with n= 30 for the dissociated cells and for the section. Further 
experiments are needed to determine the degree of co-expression of the HiR 
antibody and each of the neuronal markers.
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The triple labelling with anti Hi receptor, anti N52 and IB4 was repeated in 
frozen sections of dorsal root ganglia. A third of the N52 positive neurones 
were co-localised with the H1 receptor antibody. Moreover, nearly three 
quarters of the neurones that bind IB4 co-localised with the HiR antibody. 
Again, a small subset of the Hi receptor expressing neurones showed no co­
localisation with either IB4 or N52 (Figure 3.10C). These data are consistent 
with the previous results found in the dissociated DRG neurones.
The sensitivity of histamine responsive neurones to other inflammatory 
mediators.
As primary afferent nerve endings are exposed to a wide variety of stimuli 
including pruritic and algogenic agents, it is of interest to investigate whether 
individual sensory neurones respond to more than one agent. For example, 
do pruritic sensitive neurones also respond to algogenic agents? However, 
the responses to histamine, ATP and 5-HT are all meditated by second 
messenger pathways. Although these agents activate different receptors 
their signal transduction mechanisms all utilise calcium from internal stores to 
initiate calcium signals (see later results sections). The release of calcium 
from the internal stores will deplete them and affect the calcium responses 
evoked by subsequent stimulation. A previous study showed that DRG 
neurones which were exposed to a low concentration of histamine (100 pM), 
then washed for periods of 5, 30 and 60 minutes and the same field of cells 
were exposed to a second histamine application resulted in almost all of the 
neurones not responding to the second application (Nicolson, 2000). For
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this reason, only two agonists were tested on the same field of neurones in 
my investigations. All the agonist concentrations used for the dose response 
curve were tested on different fields of DRG neurones.
Experiments investigating the proportion of histamine sensitive cells 
responding to 5-HT (100 pM) or capsaicin (500 nM) were carried out in 
Sprague Dawley rats, hence the slightly higher percentage of cells 
responding.
Of the 11 % (n=63/563) of neurones that were histamine sensitive, two thirds 
(67%) also showed a rise in [Ca2+]i upon stimulation with 30 pM ATP. 
Therefore, a third of the histamine sensitive cells were not responsive to ATP 
(see Figure 3.11). Just over a fifth (22%) of the histamine responsive cells 
were shown to respond to 100 pM 5-HT. Capsaicin (500 nM), the hot 
component of chillies, evoked a [Ca2+]j response in nearly half (42%) of the 
histamine sensitive neurones. This data suggests that there are 
subpopulations of histamine-sensitive neurones that show different 
sensitivities to other inflammatory mediators. However, there is also a sub­
population of neurones that is sensitive to histamine and not to the other 
algogenic agents tested.
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Figure 3.11 -  Some histamine-sensitive neurones are sensitive to other 
inflammatory mediators.
The bar shows the percentage of cells that responded to histamine. The blue 
segment of the bar illustrates the proportion of these histamine sensitive cells 
that also responded to a second agonist e.g. ATP (30 pM) or 5-HT (100 pM) 
or capsaicin (500 nM). The purple segment demonstrates the proportion of 
histamine sensitive cells that did not respond to the second agonists.
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Summary of findings
> Histamine evokes a rise in [Ca2+]j in a sub-population of DRG 
neurones.
> There is a small difference in the sensitivity of neurones to histamine 
between Sprague Dawley and Wistar rats. Neurones isolated from 
Sprague Dawley rats are marginally more sensitive to histamine than 
those isolated from Wistar rats.
> Pretreatment of cultured DRG neurones with forskolin increased their 
sensitivity to low concentrations of histamine. This effect was blocked 
by the PKA inhibitor, H89 suggesting that PKA mediates this 
sensitisation. Forskolin does not affect the time course or amplitude of 
the [Ca2+]j response to histamine.
> A proportion of histamine sensitive neurones are sensitive to other 
inflammatory mediators.
> Immunostaining showed that the population of neurones expressing 
Hi receptor showed some overlap with those stained by anti­
neurofilament antibody, CGRP antibody and IB4.
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3.5 - Characterisation of the calcium response evoked by 
sensory neurones upon stimulation by 5-HT
Application of 5-HT to sensory neurones evoked a rise in intracellular calcium 
concentration in a subpopulation of cultured sensory neurones (see Figure
3.12). As the 5-HT concentration was increased from 3 nM to 100 pM the 
percentage of cells responding rose from 4% (n=2/53) to 17% (n=56/333). At 
the highest concentration of 5-HT tested around one fifth of the sensory 
neurones responded with an increase in intracellular calcium.
As mentioned earlier the length of time cells are maintained in culture can 
affect their sensitivity to some agonists. On day 1 n= 5/51 cells responded to 
100 nM 5-HT which was not significantly different from the n=5/85 (p=0.5) 
responders on day 2. For cells stimulated with 10 pM 5-HT the number of 
responders was n=12/75 on day 1 and n=17/142 on day 2 (p=0.68). The 
proportion of cells responding to 100 pM 5-HT on day 1 n=32/210 was not 
significantly different from the fraction responding on day 2 (n=7/30, p=0.29) 
and day 3 (n=17/90, p=0.5). It therefore seems that the fraction of cells 
responding to 5-HT did not change over the first three days in culture.
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Figure 3.12 -  The concentration response curve for the activation of 
DRG neurones by 5-HT.
The curve is fitted to the Hill equation with a slope of 0.36.
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The time course of the calcium responses to 5-HT.
The mean [Ca2+]j responses to 100 nM, 1 pM and 100 pM 5-HT have 
essentially the same characteristic time course and amplitude (see Figure
3.13). After application of 5-HT, the intracellular calcium rose slowly from 
baseline, reaching a peak value within 40 seconds. Unlike the responses to 
ATP and histamine, the intracellular calcium remained elevated for as long as 
the agonist was present. The responses of individual cells to 100 nM 5-HT 
are shown in Figure 3.14. Due to the small number of cells that responded to 
100 nM 5-HT (n=10/136) the variation in amplitude of individual cell 
responses is reflected in the mean response by an increase in the error bars. 
The length of time the cells were maintained in vitro also did not affect the 
pattern of the responses observed.
When 100 pM 5-HT was applied to cells the 340/380 ratio rose from a resting 
value of 0.86 ± 0.001 to a peak of 1.23 ± 0.06 within 40 seconds (see Figure 
3.13C). This increase in ratio corresponds to an increase in intracellular free 
calcium concentration of approximately 70 nM. Interestingly, the mean 
amplitude of the responses to 5-HT did not vary with concentration, 
suggesting that the response is an all or nothing event (see Table 3.2). The 
time to peak of the mean [Ca2+]j response to 5-HT was also independent of 
the concentration of the agonist.
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Figure 3.13 - The time course of the [Ca2+]j response to 5-HT.
The mean [Ca2+]j response ± s.e.m. of sensory neurones when challenged 
with (A) 100 nM 5-HT (B) 1 pM 5-HT and (C) 100 pM 5-HT. The black bar 
indicates the presence of the agonist.
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Figure 3.14 -  Typical calcium responses evoked by neurones upon 
stimulation by 100 nM 5-HT.
The black line indicates the presence of 5-HT.
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Table 3.2 -  Time to peak and amplitude of the responses to 5-HT.
5-HT
concentration
Time to Peak 
(s)
Amplitude % 
(AR/R) n
100 nM 30 38 10/136
1 pM 25 43 9/125
100 pM 40 42 56/333
n refers to the number of cells responding to 5-HT compared to the total 
number of cells tested.
The calcium entry mechanism/s mediating the response to 5-HT
As the previous section shows, a subpopulation of sensory neurones 
responded to the application of 5-HT with a rise in [Ca2+]j. Neurones have 
two sources of calcium to initiate calcium signals; an infinite extracellular 
source and a finite intracellular source (see section 1.2.5 p.37). To 
determine the calcium entry mechanism mediating the response to 5-HT, 
neurones were challenged with 100 pM 5-HT in a calcium free solution. 
Removal of extracellular calcium precludes any calcium entry through 
ionotropic channels, store operated channels and voltage-gated calcium 
channels. Hence, any observed calcium response to 5-HT would be due to 
the release of calcium from intracellular stores.
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The percentage of cells responding to 100 pM 5-HT in a calcium-free solution 
was 18% (n=17/93), which is comparable to the 17% (n=56/333 p=0.76) 
responding to 100 pM 5-HT in the 2mM standard calcium solution (see 
Figure 3.15A). This suggests that calcium released from intracellular stores 
has a major role in mediating the response of sensory neurones to 5-HT.
To determine whether the calcium response to 5-HT utilises more than one 
calcium entry mechanism; the time course of the response to 5-HT in a 
calcium-free solution was examined. The time course and amplitude of the 
response differed in the presence and absence of external calcium (compare 
Figure 3.14C and Figure 3.15B). When 5-HT was applied in a Ca2+ free 
medium, the response rose rapidly from a baseline value of 0.82 ± 0.05 to a 
peak of 1.60 ± 0.25 (n=17/93) within 30 s. After reaching a peak the 
response was not maintained as shown in the presence of calcium but 
started to decline slowly towards baseline with a time constant of 
approximately 33 s. The time to peak was marginally less than the 5-HT 
response observed in the presence of calcium. However, there was a 
significant increase (p<0.05) in the amplitude of the response to 5-HT from 
41%±7% in a calcium solution to 95%±28% in a calcium free solution. This 
evidence suggests that the initial phase of the response is due to calcium 
release from internal stores while the maintained phase requires calcium 
entry via the plasma membrane.
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Figure 3.15 - The effect of the removal of calcium on the sensory 
neurones response to 5-HT.
A) Removal of extracellular calcium does not significantly (p=0.76) affect the 
percentage of cells responding to 5-HT.
B) The absence of calcium affects the time course of the [Ca2+]j response to 
5-HT.
The slight increase in 340/380 ratio at 45 s occurs due to draining and 
replacement of solutions.
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3.6 - The 5-HT receptor subtypes mediating the response to 
5-HT in sensory neurones.
To determine which subtypes of 5-HT receptor increase intracellular calcium, 
cells were challenged with selective agonists. The 5-HT2 agonist, a-methyl 
5-HT, activates all three 5-HT2 receptor subtypes and 1-(3- 
chlorophenyl)biguanide (MCPB) is an agonist selective for 5 -HT3 receptors. 
The effects of these selective agonists on sensory neurones were compared 
with the effects of 5-HT itself.
When sensory neurones were challenged with 10 pM a-methyl 5-HT, 12% 
(n=13/112) of cells responded, which is not significantly different from the 
proportion that responded to 100 pM 5-HT (17% n=56/333, p=0.227). The 
5 -HT3 receptor selective agonist, MCPB (10 pM), evoked a response in only 
4% (n=7/155) of cells which is significantly less than the proportion that 
responded to 100 pM 5-HT (17% (n=56/333, p<0.0001) (see Figure 3.16). 
These results suggested that the response to 5-HT is primarily mediated by 
5-HT2 receptors, which are known to activate PLC.
To confirm this, cells were pre-treated with the PLC inhibitor, U73122, to 
prevent IP3 production and thus the release of calcium from intracellular 
stores. A 10 minute pre-treatment of cells with U71322, prior to the 100 pM 
5-HT challenge, evoked a response in only 4% (n=4/92) of cells, significantly 
less than those responding to 100 pM 5-HT with no pre-treatment (17% 
n=56/333, p<0.0012) (see Figure 3.16). Moreover, this value was not 
significantly different to the proportion of neurones activated by the 5-HT3 
receptor agonist, MCPB.
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Figure 3.16 -  The response to 5-HT is primarily due to activation of 
5-HT2 receptors
The asterisks indicate a significant decrease in the proportion of cells 
responding to the 5-HT3 agonist (MCPB) (p<0.0001), and cells pre-treated 
with the PLC inhibitor, U73122 (p<0.0012) then challenged with 5-HT in 
comparison with the 100 pM 5-HT control. The proportion of cells 
responding to the 5-HT2 agonist, a Me 5-HT, is not significantly different from 
that of 5-HT alone.
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Figure 3.17 - The effect of blocking 5-HT2 receptors on the [Ca2+]j 
response evoked to 5-HT.
Blocking the PLC cascade has significantly reduced (p=0.Q42) the amplitude 
of the [Ca2+]i response to 5-HT. 17% (n=56/333) of cells responded to 5-HT 
however, after pre-treatment with U73122 only 4 % (n=4/92) cells responded. 
The black line indicates the presence of the agonist.
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There was a significant reduction in the amplitude of the response evoked in 
the presence of U73122 (p=0.042) in comparison to the response of 5-HT 
alone (see Table 3.6 and Figure 3.17).
Comparison of the calcium response to 5-HT and the selective 5-HT 
receptor agonists.
As described earlier, the calcium response to 100 pM 5-HT had a slow rising 
phase and reached a peak within 40 seconds. The level was then 
maintained for as long as 5-HT was present. Interestingly, the response 
characteristics of the 5 -HT2 and 5 -HT3 receptor selective agonists differ from 
those of the response to 5-HT (see Figure 3.18).
The [Ca2+]j response to 10 pM a-methyl 5-HT had a rapid onset rising from a 
340/380 ratio of 1.0 ± 0.04 to a peak of 1.94 ± 0.25 (n=13/112) within 15 s. 
The change in 340/380 ratio is estimated to represent an increase in [Ca2+]j 
of 170 nM. The response then showed biphasic decay, a rapid fall for 15 s 
then a slow decay. The amplitude of the response to the 5 -HT2 agonist was 
significantly greater (p=0.035) than the response to 100 pM 5-HT (see Table 
3.3). Interestingly, the amplitude of the response to the 5 -HT2 receptor 
agonist was comparable to the response of 5-HT in the absence of calcium 
(see Table 3.3). The calcium response to the 5 -HT3 selective agonist, 10 pM 
MCPB, had a rapid onset rising from a baseline of 1.10 ± 0.06 to a peak of 
1.62 ± 0.09 (n=7/155) within 20 s (see Figure 3.18 C). The response then 
decayed with a time constant of 21 s.
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Figure 3.18 - The difference in time courses of the [Ca2+]j responses 
evoked by 5-HT and the 5-HT receptor selective agonists.
The figure shows the [Ca2+]j responses to A) 100 pM 5-HT, 
B) 10 pM aMe5-HT (5-HT2 agonist) and C) 10 pM MCPB (5-HT3 agonist). 
The black line indicates the presence of the agonist.
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The change in 340/380 ratio upon stimulation with the 5 -HT3 receptor agonist 
was approximately equivalent to a rise in intracellular calcium of 90 nM. The 
time to peak of the response was considerably less than that of the response 
to 100 pM 5-HT (see Table 3.3).
Table 3.3 - The variation in the characteristics of the calcium responses 
to 5-HT in different conditions and to the 5-HT receptor selective 
agonists.
Agonists
Concentration
Time
to
Peak
(s)
Amplitude
%(AR/R) N
% of cells 
responding
100 pM 5-HT 40 41 ±8 56/333 17
10 pM aMe5-HT 15 94*±25 13/112 12
100 pM 5-HT 
(Ca2+ free 
medium)
30 95*±28 17/93 18
100 pM 5-HT + 
10 pM U73122
15 14*±8 4/92 4
10 pM MCPB 20 47±8 7/155 4
The differences in the mean amplitude of calcium responses evoked by cells 
upon stimulation by a variety of different agonists were compared with 
respect to the 100 pM 5-HT control response using the unpaired Welch t test. 
The asterisk signifies a significant (p<0.05) increase or decrease in the 
amplitude of the calcium response in comparison to the control.
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3.7 -  Prostanoid-induced sensitisation of the response to 
5-HT.
Pre-treatment with PGE2 enhances the sensitivity of sensory neurones to 
histamine (Nicolson, 2000). It is therefore of interest to establish whether this 
prostanoid can also enhance the sensitivity of sensory neurones to 5-HT.
The sensory neurones were pre-treated for 45 seconds with 1 pM PGE2 then 
challenged with 5-HT. The pre-treatment itself did not elicit any responses 
but it did enhance the sensitivity of cells to 5-HT. This was demonstrated by 
a leftward shift of the 5-HT dose-response curve. At lower concentrations of 
5-HT (10 nM and 100 nM) there was a significant increase in the percentage 
of cells responding after PGE2 pre-treatment (see Table 3.4 and Figure 3.19).
Table 3.4 - PGE2 pre-treatment enhanced the percentage of cells
responding to 5-HT.
5-HT
concentration
% of cells responding
Before
p g e 2 n
After
p g e 2 n
1 nM 0 0/84 3 1/36
3 nM 4 2/53 11 7/66
10 nM 3 2/63 15* 11/75
100 nM 7 10/136 18* 27/147
1 pM 7 9/125 15 16/106
10 pM 15 29/199 19 16/83
The asterisks indicate a significant increase (p<0.05) in the percentage of 
cells responding to 5-HT after PGE2 pre-treatment in comparison to 5-HT 
alone using Fisher’s exact test.
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The sensitisation of the response to 5-HT produced by PGE2 is consistent 
with a reduction in response threshold. Furthermore, as Figure 3.19B shows, 
pre-treatment with PGE2 had no significant effect on the time course or 
amplitude of the [Ca2+]j response evoked by 5-HT. The [Ca2+]f response to 
100 nM 5-HT after 1 pM PGE2 pre-treatment had a slow rising onset 
reaching a peak in 25 s. Similar to the control cells, the evoked response 
was sustained with no decay for as long as 5-HT was present. To determine 
whether cAMP played a role in the PGE2 induced sensitisation of the 5-HT 
response the effects of forskolin were investigated. Treatment of sensory 
neurones with forskolin is known to increase cAMP levels (Nicolson 2000, 
see Figure 3.7). When sensory neurones were pre-treated for 5 minutes with 
10 pM forskolin the number of cells responding to 100 nM 5-HT significantly 
increased from 7% (n=10/136) to 18% (n=11/60 p=0.0419) (see Figure 3.20). 
This suggests a role for cAMP in the PGE2 induced sensitisation of the 
response to 5-HT.
To determine if PKA had a role in the prostanoid-induced sensitisation of the 
response to 5-HT, cells were pre-treated for 15 minutes with 300 nM H89, a 
PKA inhibitor, prior to 1 pM PGE2 pre-treatment. After PGE2 pre-treatment 
18% (n=27/147) of neurones responded to 100 nM 5-HT while after H89 and 
PGE2 pre-treatment only 8% (n=7/89 p=0.03) of cells responded to 100 nM 
5-HT (see Figure 3.20). This result is consistent with the involvement of PKA 
in the prostanoid induced sensitisation of the 5-HT response.
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Figure 3.19 - PGE2 pre-treatment enhanced the sensitivity of cells to 
5-HT.
A) The log dose response curve for 5-HT alone (black line) and for 5-HT 
after pre-treatment with PGE2 (red line).
PGEHnduced sensitisation has significantly (illustrated by asterisks) 
increased the percentage of sensory neurones responding to lower 
concentrations of 5-HT.
The curves are fitted to the Hill equation giving a slope of 0.36 for 5-HT alone 
and 1.0 for 5-HT after PGE2 pre-treatment.
B) The time course and amplitude of the [Ca2+]j response to 5-HT was not 
affected by prior PGE2 pre-treatment.
PGE2 also had no effect on the basal level of [Ca2+]j.
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Figure 3.20 - The prostanoid induced sensitisation of the 5-HT response 
can be inhibited by the protein kinase A inhibitor, H89.
The asterisks indicate significant increases, with respect to control, in the 
percentage of cells responding to 5-HT when pre-treated with 10 pM forskolin 
(p=0.Q42) or 1 pM PGE2 (p=0.007). The (+) signifies a significant decrease 
in the percentage of cells responding to 5-HT after pre-treatment with PGE2 
and 300 nM H89 (p=0.03).
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Summary of findings
> 5-HT evoked a rise in [Ca2+]j in 17% of sensory neurones
> The time course and amplitude of the evoked [Ca2+]j responses were 
independent of the 5-HT concentration.
> This response to 5-HT was mediated by the release of calcium from 
internal stores and calcium entry via the plasma membrane.
> Most DRG neurones respond to 5-HT via 5-HT2 receptors. This was 
consistent with the large proportion of cells that responded to the 
5-HT2 receptor agonist, a Me 5-HT; however, a small proportion of 
neurones were activated by the 5 -HT3 agonist, MCPB.
> Surprisingly, the removal of extracellular calcium caused a significant 
increase in the amplitude of the response to 5-HT which was 
comparable to the response of the 5-HT2 agonist, aMe5-HT.
> PGE2 sensitised the DRG neurones to 5-HT as shown by a leftward 
shift in the dose response curve.
> Pre-treatment with PGE2 did not alter the amplitude or time course of 
the [Ca2l  response.
> PGE2 sensitisation of the sensory neurones to 5-HT was mimicked by 
forskolin and blocked by the PKA inhbitor, H89. This implies that the 
sensitisation results from a phosphorylation reaction mediated by 
PKA.
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3.8 - The sensitivity of sensory neurones to ATP
Application of ATP evoked a rise in intracellular calcium concentration in a 
large fraction of isolated sensory neurones. The percentage of cells 
responding rose sharply from 14% (n=15/108) at 1 pM ATP to 69% 
(n=74/107) at 10 pM ATP. The percentage of cells responding then 
appeared to plateau between 10 pM and 100 pM ATP (see Figure 3.21).
In common with the responses to histamine and 5-HT the fraction of DRG 
neurones responding to ATP did not change during the first three days in 
culture. On day 1 n=4/33 cells responded to 1pM ATP which is comparable 
to the n=4/30 (p=1.0) responding on day 2 and n=7/45 (p=0.75) on day 3. At 
the highest concentration, 100 pM ATP, there was no difference in 
percentage of cells responding on day 1 (n=19/24) compared to day 2 
(n=49/69, p=0.6). Thus, the sensitivity of cells to each concentration of ATP 
tested was not affected by time in culture.
Variation of individual sensory neurones responses to ATP.
Figure 3.22 demonstrates that individual sensory neurones can produce very 
different [Ca2+]j signals in response to the same concentration of agonist, in 
this case 100 pM ATP. Panel A shows a bright field image of a typical field 
of DRG neurones, in which four cells of interest have been labelled. Panel B 
shows the same field of cells as pseudocolour images. The lower panel (C)
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Figure 3.21 - ATP evoked a rise in [Ca2+]j in a large proportion of 
sensory neurones.
The graph shows the number of cells responding as a percentage of the total 
number of cells tested at each ATP concentration (1 pM to 100 pM).
The curve is fitted to the Hill equation with a slope of 1.42.
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shows how the time course and amplitude of the responses differed between 
individual cells. Initially all of these cells had low levels of intracellular 
calcium shown by the blue colour of the cells (Panel B). After 45 s 100 pM 
ATP was added. After the addition of ATP, all four cells showed a rise in 
intracellular calcium. Cell 1, 3 and 4 showed moderate increase while the 
red colour of cell 2 (in Panel B) signifies a large rise in intracellular calcium. 
Cell 2 rose from a baseline of 1.04 to 1.17 initially, then a second increase 
occurred reaching a peak of 4.8 (see Figure 3.22C). The response then 
rapidly decayed towards baseline. Cells 1 and 3 have comparatively weak 
responses to ATP. Upon reaching a peak, the [Ca2+]j in all cells decay 
towards baseline. All four cells responded to the subsequent application of 
50 mM K+ (K+ depolarisation) with a marked rise in intracellular calcium.
Characterisation of the mean [Ca2+]j responses to increasing 
concentrations of ATP.
The mean response of sensory neurones to 1pM ATP rose from a baseline 
value of 1.05 ± 0.02 to a peak of 1.23 ± 0.06 over 40 s. This ratio change 
corresponds approximately to a rise of 40 nM free [Ca2+]j. Thereafter, [Ca2+]j 
decayed towards baseline (see Figure 3.23A). The [Ca2+]j response to 10 pM 
ATP reached its peak value within 20 s which was considerably faster than 
the response to 1 pM ATP (see Table 3.5). The change in ratio value of 0.5 
would give an estimated 90 nM rise in [Ca2+]j. After reaching the peak the 
calcium response slowly decayed towards baseline (see Figure 3.23B).
122
Figure 3.22 -  The variation in [Ca2+]j responses to ATP between
sensory neurones
Panel A shows a field of DRG neurones in which selected cells of interest 
have been labelled. Panel B shows pseudocolour images of the same field 
at progressive times. They illustrate the change in intracellular calcium 
concentration of cells upon the addition of ATP and 50 mM K+. Panel C 
shows the time courses in more detail for the individual neuronal responses 
to the addition of ATP at 45 s and high K+ at 150 s. The spectrum wedge 
(panel D) relates the colour change of the cells to the change in 340/380 
ratio. The scale bar in panel A represents 20 pm.
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The [C a2+]j response to 100 pM ATP had a similar time course to the 
responses to lower concentrations but reached a peak in 10 s. The response 
showed biphasic decay towards baseline with time constants of 15 s and 127  
s (see Figure 3 .23C ). The ratio changed from a baseline of 1.1 ±  0 .02  to a 
peak value of 2.19  ±  0 .17  after stimulation with 100 pM ATP. This 
corresponds to an increase in [Ca2+]j from approximately 10 nM to 230  nM. 
Thus, the time to peak and amplitude of the ATP response were dependent 
on concentration (see Table 3.5).
The patterns of the responses to ATP in individual DRG neurones were 
essentially the same (see Figure 3.24). As for the responses to 5-HT only 
the amplitude varied between cells. They did not vary with time in culture. 
Prolonged exposure to 30 pM ATP showed that [C a2+]j did not return to 
baseline for more than 200 s (see Figure 3.25).
Table 3.5 -  Time to peak and amplitude of the [Ca2+]i responses to ATP.
ATP
concentrations
Time to Peak 
(s)
Amplitude 
% (AR/R)
n
1 pM 40 55 12/105
10 pM 20 50 74/107
30 pM 15 76 114/134
100 pM 10 101 68/93
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Figure 3.23 - The time courses of the [Ca2+]j responses to ATP in
cultured sensory neurones.
The mean time course of the responses to A) 1 juM ATP, B) 10 pM ATP and
C) 100 pM ATP. The black bar indicates when ATP was present.
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Figure 3.24 -  Typical examples of calcium responses evoked in DRG 
neurones by 3 pM ATP.
Panels A, B and C show typical examples of calcium responses evoked in 
sensory neurones by 3 pM ATP. Panel D shows the mean calcium response 
profile for all the responders together with the s.e.m. The black line indicates 
the presence of ATP.
128
2.0 n n=51/64
&
§co
o
s
1.5-
1.0 - 30 pM ATP
50 100 150 200
Time (s)
250 300
Figure 3.25 -  The extended time course of the response to ATP.
The trendline on the extended time course illustrates that the response to 
30 pM ATP took more than 200 s to return to baseline. The black line 
represents the period during which the agonist was present. The time 
constant for the decay of the Ca2+ response was 30 s.
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The source of calcium giving rise to the response of sensory neurones 
to ATP
Three quarters of the sensory neurones responded to the ATP challenge with 
a rise in intracellular calcium. To determine if intracellular calcium stores 
were involved in mediating the response to ATP, cells were challenged with 
30 pM ATP in a calcium-free solution. A slight decrease in the percentage of 
neurones responding to 30 pM ATP (73% n=70/96) was observed in calcium 
free solution compared to the control (85% n=114/134) (see Figure 3.26). 
This decrease was not statistically significant (p=0.27). This suggested that 
the majority of cells responding to ATP utilised calcium from internal stores. 
Nevertheless the amplitude of the response in the calcium free solution was 
significantly (p<0.001) decreased and returned to resting level within the 
duration of the experiment (see Table 3.6 and Figure 3.27A).
Table 3.6 -  The effect of the removal of external calcium on the 
characteristics of the response to ATP.
ATP
concentrations
Time to Peak 
(s)
Amplitude % 
(AR/R)
n
30 pM 15 76±9 114/134
30 nM (Ca2+ free) 15 40*±8 70/96
The decrease in amplitude of the response to ATP upon removal of external 
calcium was found to be significant by means of Fisher’s exact test *p<0.001.
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Figure 3.26 - Removal of calcium does not significantly affect the 
percentage of cells responding to ATP
There was a non-significant decrease (p=0.27) in the percentage of cells 
responding in the absence of calcium.
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Figure 3.27 -  the effect of calcium removal on the [Ca2+]j response 
evoked by ATP
A) The removal of external calcium prior to stimulation of cells with ATP 
reduces the amplitude of the response and returns the [Ca2+]j response to 
baseline within the duration of the experiment.
B) The removal of external calcium during the ATP response prevents the 
steady state and returns the calcium to basal level.
In both A and B the red line signifies the removal of calcium and the black 
line indicates the presence of ATP. The trendline gives an indication of the 
resting level of calcium. The effect seen upon changing the solutions (e.g. at 
200 s in the Figure 3.27A) is a switching artefact.
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In Figure 3.27 B cells were stimulated with ATP in the presence of calcium. 
However, during the decay phase of the response, extracellular calcium was 
removed. The cells calcium response initially had a similar time course to the 
control, an immediate rise from baseline reaching a peak within 15s then 
decay towards baseline with a time constant of (ti 14.35s). However, the 
removal of calcium accelerated the rate of decay to baseline. These 
experiments support the notion that the initial phase of the calcium response 
to ATP is mediated by the release of calcium from internal stores while 
sustained levels during the second slow decay phase is due in part to 
calcium influx across the plasma membrane.
3.9 - The receptors mediating the ATP response in sensory 
neurones.
As mentioned in section 1.2.3 (p.32) the receptors that mediate the actions of 
ATP belong to two main classes, ligand-gated ionotropic P2X receptors and 
the metabotropic P2Y receptors (Abbracchio and Burnstock, 1994). As the 
previous experiments suggests the majority of DRG neurones respond to 
ATP by releasing Ca2+ from intracellular stores, I investigated the response of 
DRG neurones to selective P2Y agonists. The agonists chosen were 2- 
methylthioadenosine triphosphate (2MeS-ATP) and 2-methylthioadenosine 
diphosphate (2MeS-ADP). The application of 30 pM 2MeS-ATP to sensory 
neurones evoked a rise in [Ca2+]j in 72% (n=91/126) of the sensory neurones 
which was not significantly different to the 85% (n=114/134 p= 0.151) of cells
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responding to 30 pM ATP (see Figure 3.28). This supports the notion that 
most sensory neurones responding to ATP possess P2Y receptors.
However, as the specificity of the 2MeS-ATP agonist for the P2Y receptors is 
controversial, it was decided to repeat the experiments with 2MeS-ADP 
which does not activate P2X receptors (King and Townsend-Nicolson 2003). 
Application of 2MeS-ADP to sensory neurones also evoked a rise in [Ca2+]j in 
a significant proportion of DRG neurones. As the concentration of 2MeS- 
ADP increased from 1 nM to 10 pM the percentage of cells responding rose 
from 6% (n=3/51) to 67% (n=58/87) (see Figure 3.29). There was no 
significant difference (p=0.758) between the fraction of cells responding to 
the highest concentration of ATP and that responding to the highest 
concentration of 2MeS-ADP.
These results are in agreement with the earlier conclusion (see p. 130) that 
the calcium rise observed in sensory neurones in response to ATP is 
predominately mediated by P2Y receptors.
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Figure 3.28 -  The majority of the cells responding to ATP possess P2Y 
receptors.
The figure illustrates the proportion of sensory neurones responding to 30 pM 
ATP, 30 pM 2MeS-ATP and 30 pM ATP in 0 mM Ca2+.
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Figure 3.29 - The log dose response curves for 2-MeS-ADP and ATP
The graph shows the percentage of sensory neurones responding to 
increasing concentrations of 2 MeS-ADP within the range of 1 nM to 10 pM 
and ATP from 1 pM to 10 pM. The curves are fitted using the Hill equation to 
give slopes of 0.47 for the 2MeS-ADP response and 1.42 for the ATP 
response.
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The time courses of the [Ca2+]j responses to ATP and the selective P2Y 
agonists.
The time courses of the mean [Ca2+]i response to the selective agonists, 30 
pM 2MeS-ATP and 10 pM 2MeS-ADP, were similar to that obtained in 
response to 30 pM ATP. The responses showed a rapid onset, reaching a 
peak in 15 s followed by a slow phase of decay (see Figure 3.30). The 
[Ca2+]j response evoked by 30 pM 2MeS-ATP pM rose from a baseline ratio 
value of 0.88 ± 0.013 to reach a peak of 1.23 ± 0.04 (n=91/126). This was 
estimated to represent a rise in calcium of approximately 80 nM. The 
response then decayed with a time constant of 19 s. The [Ca2+]j responses 
to 10 pM 2MeS-ADP had an immediate onset rising from a baseline value of 
1.17 ± 0.02 to a peak of 1.67 ±0.1 (n=58/87). This ratio change represents a 
rise in [Ca2+]j of approximately 90 nM. The response then decayed towards 
baseline with a time constant of 19 s. However, the amplitude of the [Ca2+]j 
responses to 30 pM 2MeS-ATP and 10 pM 2MeS-ADP were considerably 
smaller than those in response to 30 pM ATP (see Table 3.7).
It is well known that some P2Y receptors are coupled to PLC which activates 
calcium mobilisation from internal stores and PKC (see Figure 4.2). If P2Y 
receptors mediate the majority of responses to ATP, application of the PLC 
inhibitor, U73122, should reduce the calcium response. Pre-treatment of 
cells with U73122 caused a significant reduction (p=0.021) in the amplitude 
of the calcium responses evoked (see Figure 3.31).
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Figure 3.30 - The time course of the [Ca2*]; responses to ATP and the
P2Y agonists 2MeS-ATP and 2MeS-ADP.
The DRG neurones were challenged with A) 30 jaM ATP B) 30 jaM 2MeS- 
ATP and C) 10 pM 2MeS-ADP.
The black bar shows the addition of the agonist at 45 s and remains present 
for the duration of the experiment.
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Figure 3.31 -  The effect of the PLC inhibitor, U73122, on the [Ca2+]i 
response to 30 pM ATP.
The time course of the responses was unchanged but the amplitude was 
reduced following pre-treatment with U73122.
The black line indicates the application of ATP.
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The observed reduction in the amplitude of responses to the P2Y agonists 
and to ATP in the presence of the PLC inhibitor, suggests that an additional 
calcium influx pathway could be contributing to the initial phase of the ATP 
response. This supports the notion of a two component response to ATP, 
with part mediated by P2Y receptors and a contribution from the ionotropic 
P2X receptors.
Table 3.7 - The time to peak and amplitude of the responses to ATP and 
the selective agonists.
Agonist
concentration
Time to 
Peak (s)
Amplitude
%(AR/R)
n =
30 pM ATP 15 76±9 114/134
30 pM 2MeSATP 15 38*±4 91/126
10 pM 2MeSADP 15 44±8 58/87
30 pM ATP + 
10 pM U73122
10 30±7 29/51
The amplitudes of the calcium responses evoked upon stimulation with the 
selective receptor subtype agonists and with U73122 pre-treatment were 
compared with the control using the unpaired Welch corrected t test. The 
asterisk indicates a significant (p<0.001) decrease in the amplitude of the 
response with respect to the control.
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Summary of findings
> The potent algogen, ATP, evoked a rise in [Ca2+]j in a large fraction of 
DRG neurones.
> The time course of the [Ca2+1 response was concentration dependent 
i.e. as the concentration increased the amplitude increased and the 
time to peak decreased.
> The non significant decrease in the percentage of cells responding to 
ATP in a calcium free solution suggests the majority of cells 
responding to ATP utilised calcium from internal stores.
> The reduced amplitude of the [Ca2+]j response when cells were pre­
treated with the PLC inhibitor, U73122 and when challenged in 
calcium free solution suggests that the amplitude is mediated by 
calcium release from internal stores and an influx pathway.
> The large proportion of cells responding to the selective P2Y agonists 
supported the involvement of these receptors in mediating the 
response to ATP.
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4 -  Discussion
Cultured DRG neurones were used as a model for the study of the 
chemosensitivity of primary afferent nerve endings. Sensory neurones were 
taken from all levels of the spinal cord. Thus, the cultured DRG cells contain cell 
bodies that would give rise to a diverse afferent population that subserve a 
variety of functions including proprioception, thermal sensation, 
mechanosensation and nociception. The subpopulations of DRG neurones can 
be categorised by their morphology, cell size, chemosensitivity and histological 
properties. Early studies using cytochemistry and electrophysiology identified 
two distinct subpopulations of neurones. The large diameter cells have soma 
which appear bright under phase microscopy. They give rise to thick myelinated 
axons. The smaller diameter cells (< 30 pm) appear phase dark and give rise to 
unmyelinated or thinly myelinated processes.
Measurement of the diameters of the sample of neurones used for the calcium 
imaging experiments reported here showed that their diameters ranged from 9 - 
31pm. The diameters of sensory neurones have previously been correlated 
with the fibre types arising from the cell (Harper and Lawson, 1985a). Cells of 
this size are known to give rise to thinly myelinated A5 fibres and unmyelinated 
C fibres (Harper and Lawson, 1985a).
This finding is consistent with the staining of DRG neurones with the neuronal 
markers IB4 , N52 and CGRP. The lectin IB4 and CGRP antibody are known to
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label small diameter unmyelinated sensory neurones. N52 antibody binds to 
cells rich in neurofilament thus are likely to be myelinated. The majority of cells 
in the field stained with either IB4 or CGRP although a small number also 
stained for N52. The N52 positive cells are likely to give rise to myelinated A 
fibres. However, the neurones giving rise to the Aa and Ap fibres are known to 
have large diameter cell bodies which correspond to the large light cell 
population described by Harper and Lawson (1985b). The diameters of cells in 
this study are therefore likely to correspond to those giving rise to thinly 
myelinated A5 fibres or unmyelinated C fibres. The small diameter DRG 
neurones transmit nociceptive and thermal information to the spinal cord (Harper 
and Lawson, 1985a) whereas the large diameter cells transmit proprioceptive 
and tactile information (Nakamura and Strittmatter, 1996).
4.1 - Measurement of intracellular calcium
Calcium imaging experiments were performed on DRG neurones loaded with 
the fluorescent calcium dye, Fura-2. This dye was used to study the intracellular 
calcium responses evoked by sensory neurones upon the application of various 
inflammatory mediators. Dual wavelength dyes such as Fura 2 have two peaks 
either in their excitation or in their emission spectrum; upon substrate binding 
there is a shift in the intensity of both of the peaks. When Fura 2 binds calcium, 
the fluorescence emitted during excitation at 380 nM falls while the fluorescence 
emitted during excitation at 340 nM increases. The peak wavelength of the 
emission spectrum is not altered and its intensity is measured at 510 nM
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(Grynkiewicz et ai, 1985). As Fura 2 is a ratiometric dye, a measure of free 
[Ca2+1 can be obtained from the ratio of the fluorescence emitted at 340 nM 
divided by the fluorescence emitted at 380 nM. The use of Fura 2 prevents 
changes in intracellular dye concentration, bleaching, dye loss and cell thickness 
affecting measurements as these factors affect the intensity of signal 
proportionally at both wavelengths. Only the calcium concentration affects the 
intensities differentially. Thus the ratio of the excitation at 340 nM and 380 nM 
directly reflects free [Ca2+]j.
The fluorescence ratio values were calibrated (see Section 2.2) to allow the ratio 
changes to be correlated with the change in [Ca2+]j (Grynkiewicz et al., 1985)
[Ca2+], = Kd[(  R-Rmin) / ( Rmax-R )](S a l Sb2)
This equation requires knowledge of the Kd value of the dye and the 
determination of the maximum ratio value and its minimum The Kd value is an 
indicator of the dye’s affinity for the agonist, in this case calcium. It depends on 
the microenvironment of the dye and the Kd value determined in a curvette is 
only an approximate estimate of the actual value. Solutions containing excess 
calcium can be used to saturate the dye in the cells to give the Rmax value. 
However, a true Rmjn value is very difficult to achieve as this requires a truly zero 
calcium solution. Measurements with calcium electrodes give values for such 
solutions in the range 10-30 nM. Moreover, calcium homeostasis is actively 
regulated by mitochondria, which are known to unload calcium at low cellular
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calcium levels. Thus, to achieve a true R min value it is necessary to uncouple 
the mitochondria which will lead to a fall in intracellular pH, altering the Kd value. 
Consequently the Rmjn value measured was probably too high. As this value 
affects the calculated free [Ca2+]j, the values given must be considered 
approximate.
4.2 - Chemosensitivity of the DRG neurones.
The cultured DRG neurones studied showed chemosensitivity to all three 
inflammatory mediators tested. Histamine, a well known pruritic, elicited a rise 
in [Ca2+]j in just over a third of sensory neurones. The DRG neurones from 
Wistar rats were slightly less sensitive to histamine than neurones from Sprague 
Dawley rats. The potent algogen ATP evoked a rise in [Ca2+]j in over three 
quarters of sensory neurones. My finding was within the range (40%-90%) of 
responding cells previously reported for the application of ATP to primary 
cultured sensory neurones (Bean, 1992, Grubb and Evans, 1999). The 
responses were either measured as a depolarising current by electrophysiology 
or indirectly by using calcium imaging to measure the change in [Ca2+]j The last 
inflammatory mediator tested, 5-HT, evoked a rise in calcium in less than a fifth 
of sensory neurones.
This study also examined whether histamine responsive neurones could elicit 
calcium responses to algogenic agents. A sub-population of histamine 
responsive neurones also responded to ATP or 5-HT or capsaicin with a rise in
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1[Ca2+]j. However, a proportion of histamine responsive cells only responded to 
histamine. This suggests that there are sub-populations of histamine sensitive 
cells with varying sensitivity to other algogenic agents. This is supported by 
electrophysiological findings showing that histamine excites two subpopulations 
of C fibres: mechanoinsensitive, thermally sensitive C fibres and
mechanoinsenstive, thermally insensitive C fibres (Schmelz et al., 2003). 
However, these fibres can also be excited by capsaicin. A previous study using 
isolated DRG neurones showed that around 60% of small diameter neurones 
are sensitive to capsaicin. Moreover, the percentage of capsaicin sensitive cells 
that respond to histamine was significantly lower than the percentage of 
capsaicin insensitive cells responding (Nicolson et al., 2002).
The time courses of the [Ca2+]j responses to the three inflammatory mediators 
differed in their characteristics: time to peak and amplitude. The mean [Ca2+]j 
response to histamine varied with the concentration applied. Application of low 
concentrations of histamine to the DRG neurones evoked a calcium response 
that reached a peak within 20 s then very slowly decayed towards baseline. 
Only at the highest concentration was there an increase in the amplitude of 
response and a decrease in the time to peak. The maximum ratio change was
0.71, which corresponds to an increase of 130 nM in [Ca2+]j.
The [Ca2+]j responses to all ATP concentrations tested had an immediate onset, 
[Ca2+]j rose to reach a peak within 10 seconds (at highest concentration). The 
[Ca2+]jthen slowly decayed towards baseline but, even after 200 seconds, [Ca2+]j
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did not return to basal levels. Time to peak and amplitude of responses were 
concentration dependent. The maximum change in ratio was considerably 
higher than with histamine with a value of 1.09 which is approximately 
equivalent to a 200 nM increase in [Ca2+],.
The time course of the [Ca2+]j response to 5-HT differed from the responses 
observed with ATP and histamine application as it was not dependent on the 
concentration applied. Characteristically, it had a slow onset and the time to 
peak was approximately 40 seconds. This was considerably slower than the 
responses to ATP or histamine. Unlike the responses to histamine and ATP, the 
response to 5-HT did not decay. The [Ca2+]j remained high for as long as the 
agonist was present. Therefore the response to 5-HT was an all or nothing 
event. The maximum change in ratio was 0.37, which corresponds 
approximately to a 70 nM rise in free [Ca2+]j.
The sensitivity of cultured DRG neurones to capsaicin has been shown to 
progressively decline over time (Nicolson 2000). This decline was shown by 
both a decrease in amplitude of the calcium response and decrease in the 
percentage of cells responding. After two to three days in culture the growth of 
neurites from the cell body is apparent (Lindsay et al., 1991). There is evidence 
of receptor migration down these processes, which could account for the 
decrease in sensitivity of the cells bodies. In this study, the cells were kept in 
culture for a maximum of three days. However, no significant decreases in the 
proportion of cells responding or alterations in the calcium response
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characteristics were observed to any of the agonists tested: histamine, 5-HT and 
ATP.
The origin of the rise in calcium
As mentioned in the Introduction, the cell has two sources of calcium to initiate 
calcium signalling, an infinite extracellular source and a finite intracellular 
source. The intracellular sources include the mitochondria and the endoplasmic 
reticulum where calcium release is mediated by two channels: the IP3 receptor 
gated channel and the ryanodine receptor gated channel. Both channels have 
been reported to be present in the DRG neurones (Kostyuk and Verkhratsky, 
1994). A previous study in rat DRG neurones, cultured under similar conditions 
to those used here, showed that the application of ryanodine failed to elicit 
[Ca2+]j responses in any neurones tested (Nicolson, 2000). The rise in [Ca2+]j 
was therefore most likely to be mediated via PLC/IP3 second messenger 
pathway. This was confirmed by experiments where the rise in calcium was 
blocked by the pre-treatment of cells with the PLC inhibitor, U73122.
The mechanisms mediating intracellular calcium responses to histamine varied 
with concentration. The calcium signal obtained in response to low 
concentrations of histamine was initially due to calcium release from IP3 
sensitive stores then sustained probably by activation of a store depletion entry 
pathway (Nicolson et al., 2002). However, in the presence of high histamine 
concentrations the evoked calcium response was mediated by store release and 
a calcium entry pathway that was independent of calcium mobilisation from the
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IP3 sensitive stores. The processes involved in mediating the calcium 
responses of DRG neurones to ATP and 5-HT had not previously been 
determined.
The removal of extracellular calcium prevents the influx of calcium, therefore any 
[Ca2+]j response in the calcium free media must be due to calcium release from 
internal stores. The percentage of cells responding to either ATP or 5-HT with a 
rise in [Ca2+]j were not significantly decreased in the absence of calcium. This 
suggests that, like histamine, the [Ca2+]j responses evoked by these agonists 
were mediated by a process requiring the release of calcium from intracellular 
stores. The receptors that mediate these responses are discussed below.
The removal of external calcium did, however, affect the time courses and 
amplitudes of the calcium responses evoked by both mediators. The [Ca2+]j 
responses to ATP in the absence of extracellular calcium had a similar rapid 
onset reaching a peak in 15 seconds. However, there was a significant reduction 
in amplitude from 76±9% to 40±8% (p=0.001) of the response. Moreover, the 
response showed a faster rate of decay and returned to the baseline. This is 
consistent with the view that the initial phase of the response was mediated by 
release of calcium from internal stores. Nevertheless, the reduction in amplitude 
seen in calcium free solution suggests that there was a significant contribution 
from a calcium influx pathway (e.g. involvement of P2X receptors or voltage 
gated calcium channels). The slow decaying component of the response was 
calcium dependent and thus could be mediated by store-operated channels
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which are activated following depletion of intracellular calcium stores (Berridge, 
1995, Putney etal., 2001). Calcium release activated calcium channels have low 
conductance and remain open over a longer time scale than voltage gated Ca2+ 
channels. Therefore activation of these channels could account for the 
prolonged decay.
Consistent with my findings, a recent study showed that application of 
extracellular ATP evoked an increase in [Ca2+]j in a subpopulation of small 
diameter rat DRG neurones. These responses were mediated by the release of 
calcium from internal stores and an influx of calcium (Sanada et al., 2002). The 
endoplasmic reticulum calcium stores can be depleted by thapsigargin, an agent 
that specifically and irreversibly inhibits calcium uptake through endoplasmic 
reticulum calcium pumps (Thastrup et al., 1990, Premack et al., 1994). Pre­
treatment of DRG neurones with thapsigargin blocked the increase [Ca2+]j in 
response to ATP and that to UTP (Sanada et al., 2002). The specific PLC 
inhibitor, U73122, prevents the formation of IP3 and thus the release of calcium 
from internal stores. When cells were pre-treated with U73122 there was a 
significant reduction in the amplitude of the calcium response evoked by cells 
upon stimulation with ATP (see Results p. 141). This is consistent with the notion 
that the response of sensory neurones to ATP is primarily mediated by release 
of calcium from internal calcium stores implicating the involvement of the G 
protein coupled P2Y receptors (Abbracchio and Burnstock, 1994). However the 
failure of U73122 to totally abolish the calcium response to ATP suggests that a 
calcium influx pathway is also involved.
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The time course of [Ca2+]j responses to 5-HT was also affected by the removal 
of external calcium. Unlike the responses to ATP, when cells were challenged 
with 5-HT in the absence of external calcium there was a significant increase in 
amplitude of the [Ca2+]j responses from 41 ±8% to 95±28% over basal levels 
(p=0.01). This result was surprising and the underlying mechanisms remain 
unclear. When cells were pre-treated with PLC inhibitor, U73122, then 
challenged with 5-HT there was a significant reduction in the amplitude of the 
calcium response. The initial phase of the response to 5-HT was mediated by 
release of calcium from internal calcium stores. The initial decay after the peak 
in the response to 5-HT in a calcium free solution suggests that the sustained 
component seen in responses in the presence of calcium is due to the activation 
of a calcium influx pathway. As for the slow component of the response to ATP, 
the sustained component of the response to 5-HT could be mediated by the 
activation of capacitative calcium entry.
4.3 - The receptors mediating the responses to histamine, 5-HT 
and ATP.
In DRG neurones, the [Ca2+]j responses evoked by the application of histamine 
were found to be mediated by the Hi receptor (Nicolson et a/., 2002). The 
selective Hi receptor antagonist, mepyramine, abolished [Ca2+]j response to low 
concentrations of histamine and significantly reduced the response to high 
concentrations (10'2 M). In contrast, selective antagonists of the H2 (cimetidine)
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and H3 (thioperamide) receptor subtypes had no significant effect on the 
response to histamine at any concentration tested (Nicolson, 2000).
Known immunohistochemical markers were used to characterise the neurones 
that expressed the Hi receptor. As noted earlier, the cultured DRG neurones 
contained a number of subpopulations of histamine responsive neurones, which 
varied in their sensitivity to other algogenic agents. Subpopulations of Hi 
receptor expressing neurones showed co-localisation with the nociceptive fibre 
markers CGRP and IB4. Thus, suggesting that Hi receptor expressing neurones 
are likely to give rise to unmyelinated, nociceptive fibres. However, there was a 
population of neurones that only stained for the Hi receptor and another small 
proportion of Hi positive neurones that showed co-localisation with the 
neurofilament marker, N52. This is consistent with the notion that some 
histamine sensitive neurones give rise to myelinated fibres.
The calcium response to 5-HT is mediated by 5-HT2 receptors.
Seven families of 5-HT receptors have been identified (Hoyer et a/., 1994). All 
except one (5-HT3) of the 5-HT receptors couple to guanine nucleotide binding 
proteins (G proteins) and regulate the intracellular concentration of second 
messengers that regulate cellular functions (see Figure 4.1). Studies using 
immunohistochemistry, in situ hybridisation and reverse transcription-PCR 
demonstrate that DRG neurones express multiple 5-HT receptor subtypes. 
mRNA for 5-HT if , 5-HT2c, 5-HT4, 5-HT5Ai 5-HT5b have been found in DRG 
neurones. Radioligand binding studies showed that functional receptors existed
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for 5-HTib, 5-HTid, 5-HT2a, 5 -HT3 on DRG neurones (Chen et al., 1998, Pierce 
eta!., 1996, Nicholson et al., 2003).
In the present study, the stimulation of D R G  neurones with 5-HT in the absence 
of external calcium showed that the responses of most cells involved the release 
of calcium from internal stores. Of the known classes of 5-HT receptors only the 
5-HT2 receptor subtypes are positively coupled to G q/n  which activates PLC/IP3 
pathway (see Figure 4.1). This leads to the mobilisation of calcium from internal 
stores and thus an elevation of cytosolic calcium concentration. 5 -HT2 and 5- 
HT3 receptor selective agonists were applied to sensory neurones to determine 
their degree of involvement in mediating the intracellular calcium responses 
evoked by D R G  neurones. The percentage of cells responding to the 5 -HT2 
agonist, a Me5-HT, was not significantly different to the control. However, only 
a small fraction of cells responded to the application of the 5-HT3 selective 
agonist, MCPB. This fraction was similar to the percentage of cells responding 
to 5-HT in the presence of the specific PLC inhibitor, U73122.
There are reports indicating that peripheral 5-HT induced nociceptive responses 
are largely mediated by 5-HT3 receptors located on sensory nerve terminals 
(Orwin and Fozard, 1986, Giordano and Dyche, 1989). Electrophysiological 
studies have shown that activation of 5-HT3 receptors causes a depolarisation 
that is due to a transient inward current resulting from the opening of a non 
selective cation channel (Robertson and Bevan, 1991). Functional 5-HT3
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receptors are expressed by DRG neurones. Nevertheless, our findings show 
that only a small fraction of DRG neurones increase [Ca2+]j in response to 5-HT 
by activation of ionotropic 5 -HT3 receptors. Our data strongly supports the 
notion that in sensory neurones the calcium response to 5-HT is predominately 
mediated by the 5-HT2 receptors
The time course of the [Ca2+]j response to the 5 -HT3 receptor agonist, MCPB, 
had an amplitude comparable to that seen in cells stimulated with 5-HT. 
Interestingly, the initial peak of the response to a Me5-HT was significantly 
greater than that in response to 5-HT yet it was comparable to the peak 
amplitude of the calcium response to 5-HT in the absence of calcium. The 
difference between the responses resides in the initial kinetics of the calcium 
response as all three responses (5-HT, a Me5-HT, Ca2+ free 5-HT) reach a 
similar end point. The difference in these responses may reflect the fact that 
many different subtypes of 5-HT receptors are expressed by DRG neurones 
(see above). Except for 5-HT3 receptors, all are G protein coupled. 5-HT2 
receptors are coupled to Gq/ Gn and activate PLC. All others regulate adenylyl 
cyclase by either up regulating or down regulating its activity. In the 
experiments discussed here 5-HT was used at a maximal concentration and will 
activate many different 5-HT receptor subtypes in addition to 5-HT2. The 
response to 5-HT could reflect the modulatory effect of another 5-HT receptor 
subtype on IP3 production which may alter the kinetics of the release of calcium
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from internal stores. However, the precise explanation for the difference in 
kinetics remains unresolved.
Of the three known 5 -HT2 receptor subtypes, 5-HT2a and 5-HT2c, have been 
shown to be present on DRG neurones (Chen et a/,.1998, Pierce et a/., 1996). 
The accumulating evidence supports the involvement of 5 -HT2A receptor in the 
mediation of pain and hyperalgesia. In behavioural studies, intradermal 
injections of 5 -HT2A receptor agonist, a Me5-HT, into the rats ipsilateral hindpaw 
resulted in a significant reduction in the paw withdrawal latency to radiant heat 
stimuli. This was not seen following the application of 5-HTiA (8-OH-DPAT) or 
5 -HT3 (2Me5-HT) receptor selective agonists (Tokunaga et al., 1998). Pre­
treatment with the 5 -HT2A receptor antagonist, ketaneserin, attenuated the 
hyperalgesia induced by injections of 5-HT in a dose dependent manner 
(Tokunaga et al., 1998). The behavioural responses (e.g. lifting and licking) 
induced by 5-HT or 5-HT induced potentiation of pain, produced by other 
inflammatory mediators, are mediated by 5 -HT2A receptors (Abbott et al., 1996).
In vivo, 5 -HT2 receptors are present on mast cells and platelets. However the 5- 
HT induced effects described above are mediated by a direct pathway as the 
elimination of all known indirect pathways that contribute to hyperalgesia failed 
to inhibit 5-HT induced hyperalgesia (Taiwo and Levine, 1992). In rat glabrous 
skin, around a third of unmyelinated peripheral afferent fibres were labelled with 
antibodies directed against the 5 -HT2A receptors (Carlton and Coggeshall,
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1997). The mRNA for 5-HT2A receptors is expressed on a small subset around 
10% of small diameter CGRP synthesising DRG neurones (Okamoto et al., 
2002). This anatomical evidence supports the idea that 5-HT can have a direct 
effect on primary afferent nerve endings. Expression of Fos-like 
immunoreactivity has been used as a marker of neuronal activation (Doi-Saika 
et al., 1997). Peripheral injection of 5-HT and 5-HT2a agonist, a  Me5-HT, 
induced Fos-like immunoreactivity in second order neurones in the dorsal horn 
that was not seen following administration of the 5 -HT3 agonist, m-CPG. The 
Fos-like immunoreactivity was reduced by 5-HT2a receptors antagonist 
ketanserin. This evidence supports the notion that 5-HT2 receptors play a role in 
the mediation of pain and hyperaglesia.
Receptors mediating the response to ATP
In man the application of ATP to a blister base elicits a sensation of pain 
(Bleehen and Keele,.1977). Subsequently, patch clamp studies on isolated rat 
sensory neurones showed that ATP gated an inward cationic current resulting in 
rapid depolarisation (Krishtal et al., 1983, Bean, 1992, Grubb and Evans 1999). 
Thus, ATP released from damaged tissue has an important role in the initiation 
of noxious signals. Its actions are mediated by the activation of specialised cell 
surface receptors, collectively called P2 purinoceptors, expressed by primary 
afferent fibres (Burnstock and Kennedy, 1985). The P2 purinoceptors can be 
subdivided into two major classes, P2X which are ligand gated cation channels
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and P2Y which are G-protein coupled receptors (Abbracchio and Burnstock,
1994).
The P2X receptor family contains 7 homomeric (P2Xi_7) and 5  heteromeric 
assemblies (P2Xi/2, P2Xi/5, P2X2/3, P2X2/6, P2X4/6) characterised by their 
biophysical and pharmacological properties (Burnstock, 1999). P2X receptors 
are cation selective channels significantly permeable to calcium with almost 
equal permeability to sodium and potassium (Ralevic and Burnstock, 1998). 
mRNA for P2Xi_6 receptors is found in dorsal root and trigeminal ganglia, while 
that of P2X7 receptors is found exclusively in cells of the immune system 
(MacKenzie et a/., 1999).
The broadly distributed P2Y receptors are coupled to heterotrimeric G proteins 
which activate a variety of intracellular second messenger systems, such as 
PLCp and adenylyl cyclase. Of the 14 P2Y receptor-like DNA sequences that 
have been cloned, only eight are accepted as functional mammalian P2Y 
receptors (P2Yi, P2Y2, P2Y4, P2Y6, P2Yn, P2Yi2, P2Y13, P2Y14,) (Boarder and 
Hourani, 1998). The P2Yi, P2Y2, P2Y4, P2Y6 and P2Yn are strongly coupled to 
Gq/n which actives the PLC / IP3 pathway, which ultimately leads to an increase 
in intracellular calcium (see Figure 4.2). Using reverse transcription PCR, 
mRNA for metabotropic P2Yi, P2Y2, P2Y4 and P2Y6 receptors have been shown 
to be expressed on adult rat DRG neurones (Sanada etal., 2002). ADP, UTP
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and UDP are selective agonists for P2Y receptors and thus are used to 
characterise the functional expression of these receptors. Moreover the potency 
of nucleotides triphosphates and diphosphates varies at different P2Y receptor 
subtypes. P2Y i receptors are adenine nucleotide preferring thus are fully 
activated by ATP and ADP. P2Y2 and P2Y4 receptor subtypes are triphosphate 
preferring and are equally responsive to ATP and UTP (Ralevic and Burnstock,
1998). P2Y6 receptors are responsive to UTP and UDP (Lustig et al., 1993, 
Ralevic and Burnstock, 1998, Bogdanov et al., 1998, Filippov etal., 1999).
Early investigations into the role of ATP receptors in pain and inflammatory 
pathways primarily focused on the P2X3 receptor as this receptor is expressed at 
high levels exclusively by a subset of small diameter nociceptive sensory 
neurones (Chen et al., 1995, Lewis et al., 1995, Burnstock and Wood, 1996). 
This was supported by evidence that noxious actions of ATP upon application to 
a human blister base (Bleehen and Keele 1977) or when injected directly into 
human skin could be inhibited by P2X receptor antagonists 
(Richardson et al., 1985). However, recent reports using gene knockout 
methods (Cockayne et al,. 2000, Souslova et al,. 2000), antisense 
oligonucleotides technologies (Barclay et al., 2002) and a novel selective P2X3 
antagonists (Jarvis et al., 2002) all suggest that P2X3 receptors are more likely to 
be involved in chronic conditions particularly chronic inflammation and 
neuropathic pain. However, it has come to light that ATP and related 
nucleotides ADP,UTP,UDP may influence sensory nerve activity by activating 
P2Y receptors. Now attention has turned to P2Y receptors and their possible
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involvement in pain. The following data shows the involvement of P2Y receptors 
in mediating the response elicited by DRG neurones upon stimulation with ATP. 
The findings reported here showed that the percentage of cells responding to 
ATP was unaffected by the removal of external calcium. This suggests that 
most cells responded to ATP via receptors that are coupled to the PLC-IP3  
pathway, implicating the involvement of metabotropic P2Y receptors. To 
determine what fraction of sensory neurones mediated their response by this 
mechanism the cells were challenged with P2Y selective agonists (2MeS-ATP, 
2MeS-ADP). The percentage of cells responding to each of the selective P2Y 
receptor agonists was not significantly different from that of the control ATP 
concentration. The P2 Y selective agonist, 2MeS-ADP, produced responses 
over a greater range of concentrations resulting in a Hill coefficient of less than 
one (nH 0.47) suggesting the involvement of more than one P2Y receptor 
subtype. A similar study showed that application of equal concentrations of ATP 
and UTP to DRG neurones in the absence of extracellular calcium evoked 
responses in a similar percentage of cells (Sanada et al., 2002). Note that the 
only P2Y receptors that are equally sensitive to ATP and UTP are the P2Y2 and 
P2Y4 receptors. This suggests that the P2Y2 and P2Y4 receptors may mediate 
the rise in [Ca2+]j observed with application of ATP to DRG neurones.
The time courses of the [Ca2+]j responses to the two P2Y agonists showed 
considerable similarity to the [Ca2+]j response to ATP. All the responses 
reached their peak in the same time. However, there was a significant reduction 
in amplitude of the calcium responses to the two selective receptor agonists.
This reduction in [Ca2+]j response amplitude was also seen when the cells were 
pre-treated with the PLC inhibitor U73122 and when challenged with ATP in a 
calcium free solution. This evidence supports the present findings of the 
involvement of metabotropic P2Y receptors acting on the PLC/IP3 pathway to 
release internal stores of calcium. However, there was a small contribution to 
this response from a calcium influx pathway (e.g. P2X receptors or voltage gated 
calcium channels).
There is some evidence to support a role for P2Y2 receptors in the mediation of 
nociception and in the sensitisation of DRG neurones to other inflammatory 
mediators. In rat sensory neurones application of low concentrations of ATP 
alone does not increase the release of substance P and CGRP. However, when 
ATP is applied prior to application of capsaicin there was a significant increase 
in the quantity of neuropeptides released by capsaicin (Huang et al., 2003). 
This sensitising role of ATP is believed to be mediated by activation of PKC 
through P2Y receptors, possibly by P2Y2 receptor subtype (Huang etal., 2003).
Intense or sustained stimulation increases the responsiveness of both primary 
afferents and second order neurones in the spinal cord. Initially these effects 
are the result of modulation of existing receptors and ion channels however, in 
the long term they will also involve changes in gene expression (Woolf and 
Salter, 2000). Activation of transcription factors may regulate these changes 
and the calcium and cAMP response element binding protein (CREB) 
transcription factor may regulate the change in sensory neurone phenotype in
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response to injury and inflammation (Ji and Woolf 2001). ATP and UTP induce 
CREB phosphorylation in a subset of adult DRG neurones, which have the 
characteristics of nociceptors, by the activation of P2Y2 receptors (Molliver et a/,. 
2002). However, the activation of P2X receptors could not induce CREB 
phosphorylation. CREB phosphorylation is calcium dependent. UTP evoked 
CREB phosphorylation is only blocked by the removal of external calcium and 
by inhibition of internal calcium store release. This is consistent with my finding 
that the amplitude of the calcium response was mediated by two processes: 
calcium influx and calcium release from internal stores.
In situ hybridisation revealed that 77% of sensory neurones expressed P2Y2 
mRNA (Molliver et al., 2002). However, only 40% of these neurones responded 
to ATP or UTP by phosphorylating CREB. Interestingly, nearly all the neurones 
which showed CREB phosphorylation were peripherin positive and small in 
diameter. Immunostaining with markers used to identify nociceptive fibres 
showed that of the neurones that were positive for CREB phosphorylation 34% 
also stained positive for CGRP while 38% of these neurones bound IB4. This 
suggests that P2Y2 receptors are expressed on a larger population than those 
expressing P2X 3 receptors which are mainly IB4 binding neurones (Bradbury et 
al., 1998, Vulchanova et al., 1998). P2Y2 receptors have also been shown to 
mediate the slow onset and sustained trains of action potentials observed in 
nociceptors activated by ATP (Molliver et al., 2002).
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In summary, my findings show that most sensory neurones respond to ATP via 
activation of P2Y receptors. This is consistent with the current evidence that the 
P2Y receptors have a role in the activation of sensory neurones and in the 
mediation of pain.
4.4 -  Mechanisms of PGE2 induced sensitisation of sensory 
neurones by inflammatory mediators.
Adaptation to a maintained stimulus is a general feature of sensory systems. 
However, there are exceptions to this rule: both itch and pain sensations do not 
adapt to stimuli that are potentially tissue damaging, but instead frequently 
exhibit sensitisation. This is observed in behavioural studies as a heightened 
perception of pain in man (Handwerker and Reeh, 1991) and as increased 
nocifensive behaviour (e.g. licking and lifting) to suprathreshold stimuli in 
animals (Ferreira et al., 1978, Hamilton et al., 1999). Upon tissue damage or 
inflammation a range of mediators including 5-HT and prostaglandins are 
released. Some of these mediators then interact with receptors or ion channels 
on sensory nerve endings to produce sensitisation. In this study the sensitising 
actions of PGE2 on the response to histamine and 5-HT have been examined.
The ability of PGE2 to alter pain perception by sensitising sensory neurones to 
noxious chemicals, thermal and mechanical stimuli is well known. Early work 
demonstrated that intradermal injection of PGE1 or PGE2 into human skin did 
not elicit pain despite producing a pronounced wheal and flare (Ferreira, 1972).
166
However, when PGEi was injected prior to bradykinin, the pain induced by 
bradykinin was greatly enhanced (Ferreira, 1972). Animal studies by themselves 
cannot elucidate the mechanism of action but showed that hyperalgesia could 
be induced by intradermal injections of activators of cAMP pathways such as 
forskolin and dibutrylcAMP (Ferreira and Nakamura, 1979, Taiwo and Levine, 
1991, Taiwo et a/., 1989). The forskolin-induced hyperalgesia could be 
prolonged by co-injection of phosphodiesterase inhibitors (which prevent 
breakdown of cAMP) (Taiwo et al., 1989) and attenuated by inhibitors of PKA 
(e.g H89) (Taiwo and Levine, 1991). Thus, behavioural models of nociception 
suggested that the increased sensitivity to noxious stimuli induced by 
prostaglandins was mediated in part by the activation of cAMP transduction 
cascade.
PGE2 pre-treatment of cultured sensory neurones showed a significant increase 
in intracellular levels of cAMP (Nicolson, 2000). This supported the notion that 
cAMP is involved in the PGE2 induced sensitisation. However, the specific role 
that cAMP played in sensitisation was unknown.
An earlier study showed that PGE2 pre-treatment increased the proportion of 
DRG neurones which responded to bradykinin (Smith et al., 2000). The 
sensitisation reduced the response threshold shown by elicitation of [Ca2+]j 
responses to low concentrations of bradykinin in initially unresponsive cells and 
an increased total number of responsive cells. This sensitisation could be
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blocked by pre-treatment with a PKA inhibitor, H89. Thus, PKA plays an 
important role in the PGE2 sensitisation of bradykinin evoked [Ca2+], responses.
Nicolson (2000) showed that PGE2 was also capable of sensitising a sub­
population of rat DRG neurones to histamine. The percentage of cells 
responding to low concentrations of histamine was increased with PGE2 pre­
treatment. The sensitisation of the histamine response could be mimicked by 
cAMP analogues e.g. (8-bromo cAMP) and inhibited by adenylyl cyclase blocker 
(e.g. tetrahydro-furyl-adenine) (Nicolson, 2000). This suggested the 
involvement of cAMP but did not fully elucidate to the mechanism by which 
cAMP induced sensitisation. The present study showed that the pre-treatment 
of cells with the PKA inhibitor, H89, prior to PGE2 pre-treatment blocked the 
sensitisation of the histamine response. This was consistent with the 
mechanism determined for PGE2 induced sensitisation of sensory neurones to 
bradykinin.
The sensitised response
PGE2 alone had no effect on [Ca2+]j in DRG neurones which is consistent with 
previous reports that at concentrations which produce sensitisation PGE2 does 
not directly activate sensory fibres. However, Smith et al., (2000) have reported 
a direct effect of PGE2 on [Ca2+]i in sensory neurones but these experiments 
were preformed on cultured DRG neurones isolated from neonates and at a 
temperature of 37°C. Most electrophysiological experiments preformed in vitro 
are conducted at room temperature (20-24°C) perhaps explaining why there is
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very limited evidence of the direct activation by prostaglandins in sensory 
neurones. The concentration of PGE2 used in these experiments to produce 
sensitisation are consistent with previous studies reporting the sensitisation of 
the bradykinin response in culture sensory neurones and within the range 
present in inflammatory exudates (Nicol and Cui, 1994, Smith etal., 2000).
Pre-treatment with PGE2 increased the proportion of neurones that responded to 
histamine with a rise in [Ca2+]j however, it did not affect the profile of the [Ca2+], 
response obtained to histamine. The sensitised response induced by cAMP 
analogues similarly had no effect on the time course or amplitude. Thus, the 
sensitising effects were due to a reduction in the threshold for a response rather 
than an enhancement of the calcium response. This is unlike the PGE2 induced 
sensitisation of the bradykinin response obtained in cultured DRG neurones 
where both the number of cells responding was increased and the bradykinin 
evoked [Ca2+]j response was enhanced (Stucky et al., 1996, Smith et a/.,2000). 
PGE2 had no effect on histamine’s induced increase in IP3 formation and thus 
it’s ability to activate the PLC/IP3 transduction pathway.
Mechanism mediating the sensitisation of the response to 5-HT
Co-injections of 5-HT and PGE2 were shown to potentiate the algogenic effects 
of 5-HT but little is known about the mechanism behind this potentiation (Hong 
and Abbott, 1994). The data presented here demonstrates that PGE2 is capable 
of sensitising a sub-population of cultured DRG neurones to low concentrations 
of 5-HT. PGE2 pre-treatment caused a left shift of the 5-HT dose response
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curve. The number of cells responding to higher concentrations of 5-HT did not 
significantly increase by pre-treatment with PGE2.
The 5-HT concentration response curve was fitted to the Hill equation with a 
slope of nH 0.36. This suggests that more than one receptor type mediates the 
response to 5-HT. However, pre-treatment with PGE2 increased the sensitivity 
of DRG neurones to 5-HT resulting in a dose response curve with a Hill 
coefficient of 1. Note that the percentage of cells responding to 5-HT prior to 
and after pre-treatment plateau at a similar value. Thus, a possible explanation 
to fit the evidence above is that the calcium response to 5-HT is mediated by 
one receptor type present in two forms, unphosphorylated and phosphorylated.
PGE2 pre-treatment did not have any effect on the characteristics of the [Ca2+]j 
response elicited by 5-HT. Pre-treatment of the cells with forskolin produced 
potentiation that was similar to that produced by PGE2. In these experiments 
intracellular cAMP was elevated by two independent methods yet both produced 
a significant increase in the number of cells responding to 5-HT. This confirms a 
significant role for cAMP in PGE2 sensitisation of sensory neurones to 5-HT.
Pre-treatment of cells with H89 inhibited the effect of PGE2 on the percentage of 
cells responding to 5-HT. This finding confirms the major role of PKA in the 
PGE2 induced sensitisation of sensory neurones to 5-HT.
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PKA involvement in the sensitisation mechanism supports the notion that the 
shift in the 5-HT dose response curve is due to the presence of one receptor 
type present in two forms. The dose response curve for 5-HT alone reflects the 
presence of both forms of the receptor. Pre-treatment of cells with PGE2 is 
known to increase cAMP which in turn activates PKA. Therefore, PKA could 
then act on the unphosphorylated receptors increasing the proportion of 
receptors in the phosphorylated state.
These findings show that PGE2 induced sensitisation of the response to 5-HT 
and histamine are mediated by PKA. A similar study showed that PGE2 induced 
sensitisation of bradykinin response was also mediated by PKA (Smith et a/., 
2000). This is supported by the findings from a study using mice with a targeted 
mutation of a PKA to investigate the role of PKA in modulating the sensitivity of 
sensory neurones to noxious thermal stimuli (Malmberg et al., 1997). The 
heightened thermal sensitivity after injection of PGE2 into the hindpaw of the 
targeted mice was reduced in comparison to the wild-type mice (Malmberg et 
al., 1997).
Thus, a common mechanism appears to be responsible for the PGE2 
sensitisation of the responses to inflammatory mediators.
How does PKA induce sensitisation?
As shown above, the proinflammatory mediator PGE2 can potentiate the 
responses of a number of inflammatory mediators, including histamine and
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5-HT. In neurones sensitised with PGE2 the characteristics of the time course of 
the [Ca2+]j responses obtained to either histamine or 5-HT were unchanged. 
Thus, sensitisation is occurring upstream of calcium release. The leftward shift 
in the dose response curves to histamine and 5-HT shows a reduction in the 
threshold of activation. This is unlikely to be due to recruitment of previously 
unresponsive cells as the total number of cells responding to 5-HT or histamine 
before and after exposure to PGE2 is similar. The fact that the sensitisation can 
be blocked by H89 is evidence for the involvement of PKA. This could occur 
through a number of mechanisms (see Figure 4.3):
1. Increased receptor affinity e.g. by phosphorylation of the receptor
2. Increase in receptor number as a result of insertion of preformed 
receptors into the plasma membrane.
3. Alteration of the G protein binding site, enhancing the sensitivity of the G 
protein to the receptor.
Consistent with my finding of a role for PKA, a recent study using Chinese 
hamster ovary cells expressing the human Hi receptor showed that PKA 
activation induced significant phosphorylation of the Hi receptor (Miyoshi et al., 
2004). In this case the authors could find no evidence for altered function but in 
this case they were looking for desensitisation rather than sensitisation.
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Evidence in favour of the second mechanism is provided by a study on \x opiod 
receptors. In this study, stimulation of the cAMP/PKA pathway regulates the 
insertion of presynaptic receptors into the membrane of GABAergic terminals 
within the rat dorsal vagal complex (Browning et al., 2004). Modulation of G 
protein binding is associated with the desensitisation of receptors (for review see 
Ferguson 2001). On the basis of current evidence, the first two mechanisms 
discussed above offer the most plausible explanation of the sensitisation. 
Nevertheless, the precise mechanism involved remains unresolved.
How could PKA induced sensitisation enhance cell excitability?
Sensitisation by inflammatory mediators increases the excitability of nerve 
endings resulting in increased firing of action potentials that are transmitted to 
the CNS. A number of studies have shown that application of PGE2 to sensory 
neurones does increase the number of action potentials evoked by noxious 
thermal, chemical (e.g. elevated levels of potassium, bradykinin) and 
mechanical stimuli (Baccaglini and Hogan 1983, Martin et al., 1987, Nicol and 
Cui 1994, Nicol et al., 1997). This study has shown that the PGE2 induced 
sensitisation of both the responses to histamine and to 5-HT are mediated by a 
cAMP-PKA mechanism. Although not covered by this study the following 
section discusses the possible mechanisms by which the PKA induced 
sensitisation of the responses to both agonists could lead to an enhanced 
excitability of cells, ultimately leading to the firing or increased firing of action 
potentials.
Figure 4.3 -  The possible mechanisms employed by PKA to induce 
sensitisation and how PKA could enhance cell excitability.
The increased sensitivity of sensory neurones to 5-HT and histamine results 
from the activation of PKA. This could occur through one of three mechanisms 
(labelled on figure):
1. An increased potency and/or efficacy of agonist at the receptor e.g. as a 
result of receptor phosphorylation
2. Insertion of preformed receptors into the plasma membrane thus 
increasing the total number of available receptors.
3. An alteration of the G protein binding site, enhancing the sensitivity of the 
G protein to the receptor.
In addition it is known that PKA can regulate cell excitability through 
phosphorylation of sodium and potassium channels. The effects PKA has on 
these channels to enhance the cells excitability are shown in the lower part of 
the figure.
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Electrophysiological recordings have shown that in responsive DRG neurones 
the application of capsaicin generates an inward current, resulting from the 
opening of a non-selective cationic channel that leads to the depolarisation of 
the sensory neuron (Heyman and Rang, 1985, Bevan and Szolcsanyi, 1990). 
PGE2 pre-treatment of DRG neurones significantly enhanced the amplitude of 
the whole cell current evoked by capsaicin through activation of a PKA pathway 
(Lopshire and Nicol 1997). Thus, the activated PKA directly modifies a site on 
the capsaicin receptor, via a phosphorylation reaction, giving rise to an 
increased sensitivity to capsaicin. This results in a larger depolarisation thus 
enhancing the excitability of these sensory neurones. Moreover, 
electrophysiological recordings from isolated rat sensory neurones showed that 
PGE2 enhanced the capacity of neurones to generate actions potentials in 
response to bradykinin (Nicol and Cui, 1994, Cui and Nicol, 1995). However, the 
PGE2 induced sensitisation of the bradykinin response is not mediated at the 
bradykinin receptor. Instead, the enhanced excitability is due to PKA induced 
modulation of other channels that contribute to the resting membrane potential 
(e.g. sodium and potassium channels) and thus regulate the capacity of 
neurones to initiate action potentials (Lopshire and Nicol 1997).
Nociceptive sensory neurones are known to express a wide variety of channels 
including at least two types of tetrodotoxjn (TTX) resistant sodium channels, 
TTX-sensitive sodium channels as well as multiple types of voltage-gated 
calcium channels and potassium channels. Voltage gated sodium channels play 
an important role in the initiation and generation of action potentials in neurones.
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Modulation of these channels can alter the properties of excitable cells and their 
responses to external and internal stimuli.
Activation of PKA by PGE2 results in a dose-dependent increase in the 
amplitude of peak tetrodotoxin -resistant currents in adult and neonatal rat DRG 
sensory neurones (England et al., 1996). The evidence that PKA inhibitors 
attenuated PGE2 induced changes in TTX-R In3 activation, inactivation and 
deactivation rates verified the involvement of PKA. The activation of PKA was 
believed to be the underlying mechanism of inflammatory mediator induced 
hyperalgesia and nociceptor sensitisation (Taiwo et al., 1989, Cui and Nicol
1995). Moreover, it has now come to light that PKA’s modulation of TTX-R In3 is 
the underlying mechanism. Thus, the enhanced firing capacity seen with the 
application of bradykinin in the presence of PGE2 is likely to result from the 
increase in the TTX resistant sodium current.
Studies using in vivo models showed increased kinase activity (PKA and/or 
PKC) in nociceptive C fibres during hyperalgesia (Dina et al., 2001, Igwe and 
Chronwall 2001). Evidence from a number of studies have implicated a role for 
PKC in nociceptor sensitization (Cesare etal 1999, Tominaga etai. 2001).
Inhibitors of PKC significantly attenuated the PGE2 induced modulation of TTX- 
resistant lNa (Gold et a/,. 1998). Thus, PKC activity is necessary for the 
expression of PGE2 induced PKA modulation of TTX-R lNa. The activation of 
particular E-type prostaglandin receptor subtypes may lead to activation of PKC.
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In the case of the PGE2 induced sensitisation of histamine and 5-HT responses, 
both agonists stimulate the IP3/PLC cascade. This ultimately leads to the 
activation of PKC which could subsequently act on the TTX-resistant sodium 
channel. However, only one subtype of PGE2 receptor activates PLC and my 
findings show no evidence that the application of PGE2 increased intracellular 
calcium.
Additionally it has been shown that increasing levels of cAMP led to suppression 
of voltage dependent potassium currents in DRG neurones (Nicol et al., 1997, 
Evans et al., 1999). These voltage gated currents have the characteristics of a 
delayed rectifier-like current. The suppression of this current is dependent on 
the activation of the cAMP-PKA transduction cascade and would increase 
neuronal excitability. The possible mechanisms leading to increased neuronal 
excitability are summarised in Figure 4.3.
4.5 Conclusions
In this study DRG neurones have been used as a model for investigating the 
actions of pruritic and algogenic agents in primary sensory nerve endings. The 
cultured sensory neurons were derived from all levels of the spinal cord and are 
therefore of mixed origin. Furthermore, the transduction processes described 
here may differ from those of nerve endings in the skin. As the mechanisms 
described involve the release of calcium from internal stores, a key issue is 
whether the endoplasmic reticulum is present in fine sensory axons and whether 
the IP3 receptor is also present. Several studies have provided evidence for the
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existence of endoplasmic reticulum in axons (Ellisman and Lindsey, 1983; 
Terasaki et al., 1994; Aihara et al., 2001). Moreover, Aihara et al specifically 
localised GFP-tagged IP3 receptors in the fine axons of cultured chick DRG 
neurons. It therefore is plausible that the findings discussed here will have some 
bearing on the peripheral mechanisms of the sensations of itch and pain.
The data presented here suggest that ATP, histamine and 5-HT all activate G 
protein linked receptors and that the subsequent generation of second 
messengers will influence the excitability of the nerve endings via effects on TTX 
resistant Na+ channels and potassium channels as discussed on pages 173- 
178. The excitation of the primary afferents is the first step of a complex 
process that lead to the conscious sensations of itch and pain. It is now 
generally accepted that there are specific pathways concerned with the 
transmission of pain. For itch the situation is less clear, and four distinct theories 
have been proposed (see McMahon & Koltzenburg, (1992). As mentioned in 
the Introduction, they are: i) the specificity theory which proposes that a specific 
set of afferents respond to pruritic stimuli; ii) the intensity theory which proposes 
that low levels of activity in nociceptive afferents signal itch while higher levels of 
activity signal pain; iii) the selectivity theory which proposes that there are no 
specific populations of afferents that signal itch, rather the sensation is mediated 
via a subset of nociceptive afferents that activate separate central connections 
responsible for the sensation of itch; iv) the pattern theory which proposes that 
itch is encoded by temporal or spatial discharge patterns in cutaneous afferents 
that also signal other modalities. The evidence reviewed in the Introduction
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(p17) suggests that the intensity and pattern theories are unlikely explanations 
for the sensation of itch. This leaves the specificity theory and the selectivity 
theory to be evaluated.
As application of histamine to the superficial regions of the skin is known to elicit 
a pure sensation of itch (Magerl et a/., 1990; Ward et al., 1996) itch can be 
considered to be a specific sensation. Moreover, the finding that some 
histamine sensitive DRG neurons are insensitive to algogenic agents such as 
capsaicin, ATP and 5-HT implies a degree of specificity in the response to 
histamine. However, it is well known that itch sensations can be masked by 
painful stimuli. It therefore seems that the specificity theory currently offers the 
most plausible explanation for the sensation of itch with the important proviso 
that a strong barrage of afferent information from pain afferent may block the 
transmission of pruritic information within the CNS.
4.6 Future research
This study has clarified the principal classes of receptor that mediate the 
responses to 5-HT and ATP. As shown in the discussion, each receptor class 
contains multiple types of subtypes and the Hill coefficient obtained from the 
dose-response curves suggested that both the responses to 5-HT and ATP 
probably involved multiple receptor subtypes. Receptor subtype selective 
agonists and antagonists (where available) could be used to further investigate 
the receptors subtypes involved. Characterisation of the 5 -HT2 receptor 
subtypes could be further investigated with the 5 -HT2A antagonist, ketaneserin.
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However, as the selectivity of the antagonists is not always reliable, in situ 
hybridisation and binding studies could be also used to help clarify exactly which 
receptors are present and whether they are functional. Immunohistochemistry 
could also be used to determine the location of different receptor subtypes on 
the DRG neurones and on the primary afferents. This technique could also be 
used to examine whether the receptors for the various inflammatory mediators 
were co-localised.
This study additionally investigated the PGE2 induced sensitisation of the [Ca2+]i 
responses to histamine and 5-HT. PKA was found to mediate this sensitisation 
however it is not known how this occurs. The neuronal protein, which is 
phosphorylated by PKA, whether this is an ion channel, part of the receptor or a 
G protein remains to be resolved. Currently, it is not known if the responses to 
ATP can also be sensitised and if this is the case, whether PKA also mediates 
this sensitisation.
Once the receptor subtypes and transduction processes have been clarified, the 
next logical step would be to investigate how selective activation of the different 
receptor subtypes influences the excitability of the sensory neurons.
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6.0 APPENDIX
6.1 DRUGS AND SOLUTIONS
Unless otherwise stated all laboratory drugs and chemicals were obtained 
from Sigma-Aldrich Company Ltd. (The Old Brickyard, New Road, 
Gillingham, Dorset SP8 4XT).
Alpha Diagnostic International (5415 Lost Lane, San Antonio, TX 78238, 
USA)
Rat Histamine 1 Receptor (HiR) Antibody, Rat HiR control peptide.
Alomone Laboratories (Shatner Centre 3, PO Box 4287, Jerusalem 91042, 
Israel).
Mouse Nerve Growth Factor (mNGF 2.5s) Grade 1.
Bio-Rad Laboratories Ltd (Marylands Avenue, Hemel Hempstead, 
Hertfordshire) 4-15% gradient gels
Calbiochem Novabiochem (Merck Biosciences Ltd.Boulevard Industrial 
Park, Padge Road, Beeston, Nottingham, NG9 2JR)
Forskolin (7b-ace, 1-[6-((17b-3-Methoxyestra-1,3,5(10)-trien-amino)hexyl]- 
1 H-pyrrole-2,5-dione (U73122)
Cayman Chemicals (1180 East Ellsworth Road, Ann Arbor, Ml 48108, USA) 
Prostaglandin E2
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Invitrogen (3 Fountain Drive, Inchinnan Business Park, Paisley, UK) L- 
Glutamine, Penicillin, Streptomycin, Laminin, Benchmark pre-stained protein 
ladder
Jackson Immuno Research Labs (P.O. Box 9, 872 West Baltimore Pike, 
West Grove, PA, USA) Donkey anti rabbit fluorescein isothiocyanate (FITC), 
Donkey anti rabbit/goat tetramethyl rhodamine isothiocyanate (TRITC)
JRH Biosciences (13804, West 107th Street, Lenexa, KS, USA) Ham’s 
nutrient mixture F14 modified with L-Glutamine and 1.176gL sodium 
bicarbonate
Molecular Probes (Cambridge bioscience, 24/25 Signet Court, Newmarket 
Road, Cambridge, CB5 8LA)
Fura-2 acetoxymethyl ester, Pluronic acid
Tocris Cookson (Northpoint, Fourth Way, Avonmouth, Bristol, BS11 8TA) 
a-Methyl-5-hydroxytryptamine maleate, m-Chlorophenylbiguanide 
hydrochloride, 2-Methylthioadenosine triphosphate tetrasodium,
202
Solutions 
Culture Media
To each 500 ml bottle of Ham’s F14 was added 1 mM L-Glutamine, 5 mis 
penicillin-streptomycin (5000 lU/ml penicillin and 5000 ng/ml streptomycin) 
and 20 mis USG (to give 4%)
Buffer Solution 
HEPES buffered Na Locke
NaC1140 mM, KCI 5mM, Mg Cl2 1 mM, Ca Cl2 2 mM, HEPES 15 mM 
Glucose 5.5 mM.
HEPES buffered High K+Locke
NaCI 50 mM, KCI 95 mM, Mg Cl2 1 mM, Ca Cl2 2 mM, HEPES 15 mM 
Glucose 5.5 mM.
HEPES buffered 0 mM calcium Na Locke
NaCI 140 mM, KCI 5 mM, Mg Cl2 1 mM, HEPES 15 mM Glucose 5.5 mM.
Western Blot Solutions 
5X Running Buffer
15.1 g Tris Base, 94 g Glycine, 50 mis 10% SDS- final volume 1 litre 
10X Transfer Buffer
72 g Glycine, 15 g Tris Base -  final volume 1 litre
Before use 100 mis 10X transfer buffer, 200 mis menthanol, 5 mis 10% SDS 
-  final volume 1 litre
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Loading Buffer
187.5 mM tris HCI pH 6.8, 30% glycerol, 6% SDS, 0.1% Bromophenol blue, 
150 mM DTT, 1:10 mercaptoethanol.
TBST (Tris Buffered Saline Tween) Buffer
150 mM NaCI, 25 mM Tris HCI pH 7.4, 0.5 mis Tween 20 -  final volume 1 
litre.
Lysis Buffer
50 mM Tris HCI pH 7.4, 150 mM NaCI, 1% Triton-X-100, 1% SDS, Aprotinin 
(1:100 stock from sigma diluted), 1 mM PMSF, 1 pg/ml pepstatin.
Immunohistochemistry
Antibody Buffer Solution
Phosphate buffered saline, triton x100, 0.02% sodium azide.
Mounting Medium
Phosphate buffered saline / Glycerol (1:3) containing 25 mg/ml diazobicyclo-
2-2-octane.
Blocking solution
10% Marvel in phosphate buffered saline.
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6.2 -  Western Blot Protocol
Sample Preparation
• Suspend the dorsal root ganglion neurones in lysis buffer (see 
appendix 6.1) and homogenised using a clean micropestle.
• Spin the sample then remove the supernatant to a fresh eppendorf 
and add loading buffer (one third of the total volume).
Preparation of Gradient SDS Gels
• Assemble gels in the gel apparatus with small plates facing inwards
and clamp onto mount to form tight seal.
• Pour running buffer into the chamber between gels covering the wells 
then pour the remaining buffer into the external tank.
• Using fine gel loading pipette tips load equal volumes of sample
(30 pi -50  pi) to each well.
• Load the pre-stained molecular weight markers into the reference 
lanes.
• Run gel at a constant 100V for 1.5-2 hours.
Transfer of Gel
• Dismantle the gel tank. Check the markers have transferred
• Soak sponges, filter paper, nitrocellulose membrane in transfer 
buffer. Assemble on transfer cassette in following order -  sponge, 
filter paper, gel, nitrocellulose membrane, filter paper and finally 
sponge.
• Try to remove any air bubbles before closing the cassette and 
placing in the tank.
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• Place ice block next to transfer apparatus, fill tank with transfer buffer 
and run transfer at constant 0.4A for 1.5-2 hours.
Immunoblotting
• Dismantle the transfer apparatus and remove the membrane, cut the 
top right hand corner to aid orientation later.
• Place membrane in small tray containing 10% milk solution, cover 
with cling film and leave on a rocker for one hour at room 
temperature.
• .After an hour replace the 10% milk solution with a 5% milk solution 
containing the required primary antibody at an appropriate dilution.
• Cover the tray with cling film and leave on a rocker is covered and 
leave on a rocker overnight at 4°C.
• Wash membrane three time for fifteen minutes each time in a large 
volume of TBST (see appendix 6.1)
• Place membrane in tray containing the secondary antibody diluted to 
the required concentration in 5% milk solution. Covered with cling 
film and place on a rocker at room temperature for 1-2 hours.
• Wash membrane three time for fifteen minutes each time in a large 
volume of TBST (see appendix 6.1)
Chemiluminescent Detection
• Mix equal volumes of the detection reagent 1+2 in a tube to give an 
adequate working volume.
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• Remove blots from the final TBST wash and place membrane protein 
side up on a large piece of cling film.
• Pipette the ECL working reagent directly onto the membrane and 
leave at room temperature for 2-3 minutes.
• Blot off the excess solution, cover the membrane with cling film, 
making sure there are no ceases, and place in xray cassette.
• In dark room expose the blot to the Xray film for a short period of time 
(1-2 minutes).
• To develop the exposed film immerse quickly into developing solution, 
wash in water, transfer to fixer and finally wash. Hang up to dry.
• When dried compare the bands on the X film with the molecular 
weight markers on the blot to give an estimation of the size of the 
proteins obtained.
207
